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ABSTRACT
BAYESIAN STATISTICAL METHODS IN GENE-ENVIRONMENT
AND GENE-GENE INTERACTION STUDIES
by
Changlu Liu
Biomathematics and Biostatistics
Graduate School of Biomedical Sciences
UTHealth and MDACC
August, 2013
Complex diseases such as cancer result from multiple genetic changes and envi-
ronmental exposures. Due to the rapid development of genotyping and sequencing
technologies, we are now able to more accurately assess causal effects of many genetic
and environmental factors. Genome-wide association studies have been able to lo-
calize many causal genetic variants predisposing to certain diseases. However, these
studies only explain a small portion of variations in the heritability of diseases. More
advanced statistical models are urgently needed to identify and characterize some
additional genetic and environmental factors and their interactions, which will enable
us to better understand the causes of complex diseases. In the past decade, thanks to
the increasing computational capabilities and novel statistical developments, Bayesian
methods have been widely applied in the genetics/genomics researches and demon-
strating superiority over some regular approaches in certain research areas. Gene-
environment and gene-gene interaction studies are among the areas where Bayesian
iv
methods may fully exert its functionalities and advantages.
This dissertation focuses on developing new Bayesian statistical methods for data
analysis with complex gene-environment and gene-gene interactions, as well as extend-
ing some existing methods for gene-environment interactions to other related areas.
It includes three sections: (1) Deriving the Bayesian variable selection framework
for the hierarchical gene-environment and gene-gene interactions; (2) Developing the
Bayesian Natural and Orthogonal Interaction (NOIA) models for gene-environment
interactions; and (3) extending the applications of two Bayesian statistical methods
which were developed for gene-environment interaction studies, to other related types
of studies such as adaptive borrowing historical data.
We propose a Bayesian hierarchical mixture model framework that allows us to
investigate the genetic and environmental effects, gene by gene interactions (epistasis)
and gene by environment interactions in the same model. It is well known that, in
many practical situations, there exists a natural hierarchical structure between the
main effects and interactions in the linear model. Here we propose a model that in-
corporates this hierarchical structure into the Bayesian mixture model, such that the
irrelevant interaction effects can be removed more efficiently, resulting in more robust,
parsimonious and powerful models. We evaluate both of the ’strong hierarchical’ and
’weak hierarchical’ models, which specify that both or one of the main effects between
interacting factors must be present for the interactions to be included in the model.
The extensive simulation results show that the proposed strong and weak hierarchical
mixture models control the proportion of false positive discoveries and yield a powerful
approach to identify the predisposing main effects and interactions in the studies with
complex gene-environment and gene-gene interactions. We also compare these two
models with the ’independent’ model that does not impose this hierarchical constraint
v
and observe their superior performances in most of the considered situations. The
proposed models are implemented in the real data analysis of gene and environment
interactions in the cases of lung cancer and cutaneous melanoma case-control studies.
The Bayesian statistical models enjoy the properties of being allowed to incorporate
useful prior information in the modeling process. Moreover, the Bayesian mixture
model outperforms the multivariate logistic model in terms of the performances on
the parameter estimation and variable selection in most cases. Our proposed models
hold the hierarchical constraints, that further improve the Bayesian mixture model
by reducing the proportion of false positive findings among the identified interactions
and successfully identifying the reported associations. This is practically appealing
for the study of investigating the causal factors from a moderate number of candidate
genetic and environmental factors along with a relatively large number of interactions.
The natural and orthogonal interaction (NOIA) models of genetic effects have pre-
viously been developed to provide an analysis framework, by which the estimates of
effects for a quantitative trait are statistically orthogonal regardless of the existence
of Hardy-Weinberg Equilibrium (HWE) within loci. Ma et al. (2012) recently de-
veloped a NOIA model for the gene-environment interaction studies and have shown
the advantages of using the model for detecting the true main effects and interac-
tions, compared with the usual functional model. In this project, we propose a novel
Bayesian statistical model that combines the Bayesian hierarchical mixture model
with the NOIA statistical model and the usual functional model. The proposed
Bayesian NOIA model demonstrates more power at detecting the non-null effects
with higher marginal posterior probabilities. Also, we review two Bayesian statistical
models (Bayesian empirical shrinkage-type estimator and Bayesian model averaging),
which were developed for the gene-environment interaction studies. Inspired by these
Bayesian models, we develop two novel statistical methods that are able to handle the
vi
related problems such as borrowing data from historical studies. The proposed meth-
ods are analogous to the methods for the gene-environment interactions on behalf of
the success on balancing the statistical efficiency and bias in a unified model. By ex-
tensive simulation studies, we compare the operating characteristics of the proposed
models with the existing models including the hierarchical meta-analysis model. The
results show that the proposed approaches adaptively borrow the historical data in a
data-driven way. These novel models may have a broad range of statistical applica-
tions in both of genetic/genomic and clinical studies.
vii
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1. Introduction
1.1 Background
Complex diseases have been recognized as resulting from the effects of multiple
genetic changes and environmental exposures, which usually interact to cause the dis-
eases and therefore are difficult to investigate by traditional approaches. The advances
in genome-wide association studies (GWAS) have provided powerful tools to study
the genetic contribution to complex diseases. In the past few years, a large number
of robust associations between chromosomal loci and diseases have been identified by
GWAS [1] [2]. However, the genetic variants identified by GWAS only explain a small
proportion of the heritability of diseases [3] and it is speculated that gene-environment
and gene-gene interactions may explain some of the missing heritability [5]. Moreover,
typical applications of GWAS analysis have not considered the gene-environment and
gene-gene interactions [4]. Accurately completing association studies with interac-
tions remains a challenging task for researchers. We are therefore trying to develop
advanced statistical methods to investigate this problem to better understand the
disease heritability and causality.
Unlike the Mendelian diseases for which the single genetic variants affect the
outcomes, complex diseases and disorders have been known to be affected by multiple
genetic and environmental factors [4] [5]. Approaches for modeling gene-gene (GxG)
and gene-environment (GxE) interactions among risk factors have been moderately
investigated in research areas such as genetics, genomics, evolution and epidemiology
in recent years [6] [8]. The term ’interaction’ has several meanings in different study
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backgrounds. Here we focus our interests on the definition of interaction as an effect
departure from the additivity of the main effects. The genetic expression level of
certain genes can be inhibited or induced by certain environmental factors. Also, the
environmental factors’ effects could be adjusted by the effects from genetic factors.
In this dissertation, we will explore the models of interactions based on the statistical
definitions.
1.2 Definition of Gene-Environment and Gene-Gene Interactions
In order to correctly analyze and interpret gene-environment and gene-gene inter-
actions, it is first essential to describe how the interactions are defined. The challenge
in statistical analysis of interaction studies is that the gene-environment and gene-
gene interactions are not uniquely defined in the literatures. To avoid ambiguity of
concepts, in this section I will first discuss the ’interaction’ in statistical views and
then introduce the concrete concepts commonly applied in genetic studies. Also, the
biological interpretation of statistical interactions will be discussed.
1.2.1 Statistical Interaction
The term ’interaction’ usually refers to a phenomenon in which several variables
jointly influence the outcome. The target in Quantitative Trait Locus (QTL) and
association studies is to investigate the relationship between the outcome (trait) Z
and the genetic factors X = (X1, ..., XJ) and environmental factors Y = (Y1, ..., YK),
where J and K are the total number of factors considered respectively. This can be
expressed in a statistical model as
f(E(Z)) = Φ(X, Y ) = Φ(X1, ..., XJ , Y1, ..., YK) (1.1)
where f(.) is the link function, which connect the observed outcome and the factors;
E(.) is the expectation of response trait and Φ(.) is an unknown function that connects
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the factors to the transformation of the expectation. For a quantitative (continuous)
trait, a normally distributed response may be assumed. For a qualitative (discrete)
trait, we may assume it follows Bernoulli distribution. Were the parameters in Φ(.)
presented in a linear way, the model would be generally termed as ’Linear Model’.
For example, in the QTL analysis, the trait is usually assumed normally distributed
and a linear regression model would be built to identify the predisposing loci from a
candidate locus set.
Usually multiple genetic and environmental factors are believed to jointly affect
the outcome. In this dissertation, we first restrict our attention to the simplest
case of two-way (factor) interactions. There are three possible types of interactions
for the genetic and environmental factors: gene-environment(GxE), gene-gene(GxG)
and environment-environment(ExE) interactions. The ExE interactions could be in-
cluded as covariates in the model and the environmental measures usually include
considerable measurement errors, so researchers mainly focus on GxE and GxG in-
teractions. It is worthwhile to mention that, although the formulation of GxE and
GxG interactions are similar, the interpretations are rather different. With only one
genetic factor X1 and one environmental factor Y1, if the two factors do not interact,
then by the definition of additivity, Φ(X1, Y1) = Φx(X1) + Φy(Y1), where Φ is the
function of the variable [9]. This implies that the environmental effect of Y1 will not
affect the genetic effect of X1. Here, the environmental effect is often not of main
interest, but could be an potential confounding factor. In GxG interactions, we first
consider two genetic factors X1 and X2. If the functions of two factors could be placed
by two separate functions Φ(X1, X2) = Φx1(X1) + Φx2(X2), then it would be claimed
that the genetic effect of X1 does not depend on the genetic effect of X2 and vice
versa. If the condition is not satisfied, the response due to to a change in one factor
will be dependent on the level of another factor. In the model with multiple genetic
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and environmental factors, we regard the interactions as a product term of the main
effect variables. In the most common cases, the genetic factors have 3 levels (0,1,2)
and environmental factor has 2 levels (0,1). We naturally start to build up a model
for a two-way GxE interaction as
Φ(X1, Y1) = a+ µj + τk + σjk
Φ(0, 0) = a
Φ(1, 0) = a+ µ1
Φ(2, 0) = a+ µ2
Φ(0, 1) = a+ τ1
Φ(1, 1) = a+ µ1 + τ1 + σ11
Φ(2, 1) = a+ µ2 + τ1 + σ21 (1.2)
where α is the baseline (intercept), µ1 and µ2 are the main effects for genetic levels
1 and 2, τ1 is the main effect for the environment factor and σ11 and σ21 are the two
interactions between the genetic and environmental factors. In practice, we usually
place the above terms under the linear model framework. Since the genetic factor has
3 levels, two dummy variable X11 and X12 should be created to represent the levels
of the genetic factor, and then the model will become
Φ(X1, Y1) = α + β1X11 + β2X12 + γ1Y1 + θ1X11Y1 + θ2X12Y1 (1.3)
where for the dummy variables, X11 = 1 and X12 = 0 if X1 = 1; X11 = 0 and X12 = 1
if X1 = 1; X11 = 0 and X12 = 0, if X1 = 2.
1.2.2 Interaction in Genetic Studies
The genetic factors X1, ..., XJ usually take on three values (0,1,2) for example, to
indicate the number of minor alleles at the locus, so one level will be excluded as the
baseline or reference effect. When we consider the GxG interactions, in the simplest
4
case of 2 genetic factors, there will be 4 main effects and 4 interactions. In human
genetic association studies, this model is named co-dominant model [10].
Φ(X1, X2) = α + (X1aa1 +X1dd1) + (X2aa2 +X2dd2)
+(X1aX2aaa12 +X1aX2dad12 +X1dX2ada12 +X1dX2ddd12) (1.4)
Here X1a and X1d are the variables for X1 with X1a = 1 if X1 = 1; X1a = 0 otherwise,
and X1d = 1 if X1 = 2; X1d = 0 otherwise. Here a1, a2, d1 and d2 are the main effects
and aa12, ad12, da12 and dd12 represent the interactions. There are alternative ways
to code the variables X1a, X1d, X2a, and X2d. An alternative widely used method is
the Cockerham model [7], which codes the main effect variables as
X1a = X1 − 1, X2a = X2 − 1
X1d = (X1 − 1)(3−X1)− 0.5, X2d = (X2 − 1)(3−X2)− 0.5 (1.5)
where a1 and a2 are the additive effects, d1 and d2 are the dominance effects and aa12,
ad12, da12 and dd12 correspond to the interactions of additive by additive, additive by
dominance, dominance by additive and dominance by dominance, respectively.
1.3 Generalized Linear Model for Interaction Studies
For studying various types of phenotypes (disease status or complex trait), the
generalized linear models have been implemented for detecting the interactions [10].
A generalized linear model is composite of three parts: link function, linear predictor
and the distribution of phenotypes [11]. The linear predictor is a linear combination
of the independent variables. The link function relates the mean of the outcome to
the linear predictor. So if the link function f(.) is an identify function, the model
will degenerate to be a linear regression model. The phenotype Z can be assumed
to follow different types of distributions such as Normal, Logistic, Binomial, Log-
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normal and Poisson, depending on the response outcomes. Usually for a count type
of response, a Poisson distribution is assumed and the link function will be
f(E(Z)) = log(E(Z)) (1.6)
For a binary outcome that is Bernoulli distributed, the link function f(E(Z)) could
be any of the followings:
logit: log(
E(Z)
1− E(Z))
probit: Ψ(E(Z))
cloglog: log(−log(1− E(Z))) (1.7)
Modeling the GxE and GxG interactions will be more complicated in the gen-
eralized linear model than in the linear regression model due to the link function
connecting the response and the linear predictor. In the generalized linear model, the
genetic and environmental effects correspond to a transformation of the expectation
of the response. For example, in a logistic regression, the estimates of effects will be
based on the scale of the log odds of success log Pr(Z=1)
1−Pr(Z=1) . However, some generalized
linear models may be viewed as a linear regression model with a latent variable [12].
For example, in the logistic model with a latent variable T , the model will be
T ∼ N(Φ(X, Y ), σ2)
Z = 1 if T > 0
Z = 0 if T < 0 (1.8)
This type of formulation by latent variables provides a computational efficient ap-
proach to model the effects, that it is widely applied in Bayesian modeling. It also
renders a convenient way to explicitly interpret the study results from the generalized
linear model.
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The genetic and environmental effects and interactions estimates depend on the
link function. It is possible that some interaction results will change when the selected
link functions change. This is analogous to the scenario of log-normal transformation
in a simplified linear regression model [13], for example,
Z = X ∗ Y
log(Z) = log(X) + log(Y ) (1.9)
An interaction is called ’removable’, when a transformation of the outcome scale
exists to induce additivity [14]. It is of great importance to decide if the detected
interaction is removable or not. If some interactions could be removed by changing
the link function or making a simple transformation, the resulting model fitting would
be improved and the interpretation would be more straightforward. For a continuous
outcome, the Box-Cox transformation could be attempted to transform the outcome
or the linear predictor to fit the data. For a binary outcome, the proposed different
generalized linear model could be implemented separately for the same dataset to
select the most efficient model. When there are no interaction terms in a generalized
linear model, it is still possible that the effects of one factor depends on the effects
of other factors in the model due to the link function f(.). However, this dependence
will not affect the transformed value of the expected value of the response f(E(Z)).
As long as the interaction terms included improve the model fit, we will claim that
the model captures some existing interactions between variables by adding the in-
teraction terms. Bayesian hierarchical methods actually provides effective tools to
analyze the data using different models in which the GxE and GxG interactions can
be investigated simultaneously.
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1.4 Existing Models for Detecting Interactions
To detect interactions involves the specification of statistical models and the find-
ings will depend on the selected models. There are many different methods for detect-
ing GxE and GxG interactions such as the two-stage design [15], multifactor dimen-
sionality reduction (MDR) [16], and tree based model (random forest) [17], among
many others. Here, we will only focus on introducing penalized regression models
and Bayesian hierarchical models used in the GxE and GxG interactions, based on
which our proposed models in chapters 2 and 3 are built.
1.4.1 Penalized Regression Model
Statistical variable selection techniques have been deeply explored in statistics.
When we seek to evaluate the effects of many potential variables with a limited num-
ber of observations, finding the predictors that parsimoniously explain the variations
in the dependent variables is rather challenging. There are also many statistical mod-
els that have been proposed for variable selection with considerations of interactions.
In the classical statistical models, the estimation of effects are achieved by ob-
taining the Maximum likelihood estimation (MLE). But a generalized linear model
with large number of variables or correlated variables often fails to identify the true
affecting variables. A standard remedy is to add a penalty function to the likelihood
function, enabling the selection of variables by certain criteria:
J(Θ) = log(L(Θ|data))− pi(Θ) (1.10)
where J(Θ) is the penalized likelihood function, L(Θ|data) represents the likelihood
and pi(Θ) is the penalty function. Adding parameters will increase the value of
L(Θ|data) but also increase the penalty pi(Θ). Therefore, J(Θ) is a balancing com-
bination of the model fit and complexity. By applying the penalty function pi(Θ),
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we may constrain the parameters under the traditional frameworks or place prior
information under Bayesian framework. While the penalized likelihood model can
stabilize the estimation of the model, it also provides a criterion for model selection
and comparison. The selection of the penalty function pi(Θ) controls the general per-
formance of the penalized likelihood approach. Small penalties will correspond to the
selection of models with large number of parameters that are less biased but will bring
large variances due to the correlation within parameters. In contrary, large penalties
will lead to reduced models that will generate relatively large bias and small variance.
Many statistical methods for variable selection utilize this penalized likelihood
framework, such as the Akaike Information Criteria (AIC) [18] and Bayesian Infor-
mation criteria (BIC) [19]. In AIC, the penalty pi(Θ) is related to the total number of
parameters dim(Θ) included in the model. The BIC criteria is related to the number
of parameters and the total sample size N of the data.
AIC: − 2log(L(Θ|data)) + 2dim(Θ)
BIC: − 2log(L(Θ|data)) + dim(Θ) ∗ ln(N) (1.11)
These variable selection criteria have been applied in multiple QTL mapping studies
[20]. However, due to the large number of potential variables, these criteria tend
to incorrectly include many spurious loci. Therefore it may not be appropriate for
the QTL mapping [22]. When interactions are also included in the model, the total
number of parameters will increase substantially. Some modifications of these criteria
have been applied for the interaction studies, such as assigning different penalties to
the main effects and interactions [23] as:
log(L(Θ,Γ|data))− λΘdim(Θ)− λΓdim(Γ) (1.12)
where λΘ and λΓ represent the different tuning parameters for the penalties on the
main effects and pairwise interactions. Cross-validation could be applied to find the
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optimal values of these tuning parameters. Forward or backward stepwise selection
procedures might also be attempted based on these penalized likelihood models. Usu-
ally, the above penalized likelihood approach is called L0 penalty, which involves the
total number of parameters in the modeling process while neglecting the scale of the
parameters.
Another popular penalized likelihood approach is the Least absolute shrinkage and
selection operator (Lasso) proposed by [24], which is referred to as the L1 penalty.
The estimates of parameters in Lasso are obtained by maximizing the likelihood
function subject to a constraint on the sum of the absolute values of parameters in
the regression models ||Θ||1 < L, which is equivalent to maximizing the penalized
likelihood function:
log(L(Θ|data))− λ||Θ||1 (1.13)
There is also another group of approaches that are based on the L2 penalty on the
regression coefficients:
log(L(Θ|data))− λ||Θ||22 (1.14)
where ||Θ||2 =
√∑
J θ
2
j . This regression is called ridge regression and it can ef-
fectively handle the problem of collinearity and highly correlated variables but can
not select variables. A logistic model with L2 penalty has been proposed to handle
the gene-gene interactions in case-control studies [21]. The model with quadratic
penalties can simultaneously fit a large number of factors and their interactions in a
stable way. However, it can not shrink any parameters directly to zero as Lasso dose
and thus does not perform the variable selection to resolve important signals versus
noises. People also applied a forward selection method based on this penalty function
to select the variables [25].
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Lasso is an effective tool for the analysis of genetic interactions by shrinking
the parameters to zero to perform variable selection [28]. A variety of optimization
approaches for Lasso have been proposed, which make it possible to be applied in
large scale studies [26] [27]. Lasso logistic regression was also applied for genome-
wide association analysis in case-control analysis [28]. In the studies, the number
of predictors is fixed such that the tuning parameter λ can be pre-determined by
running cross validation. For a given λ, the coordinate descent algorithm was applied
to select the important genes and interactions. Tanck (2006) [29] also applied the
Lasso regression model to detect the gene-gene interaction in association studies with
L2 penalty for the main effects and L1 penalty for the interaction effects. Therefore,
in the modeling process the effective interaction terms can be selected, while all the
main effects are retained.
1.4.2 Bayesian Hierarchical Model
Hierarchical models have been applied in the high-dimensional data analysis in-
cluding QTL mapping and association studies [22]. The models are parameterized
in a structured way so that some dependences among the variables are incorporated,
thereby fitting a model with a large number of predictors. In non-hierarchical mod-
els, model fitting is usually not stable due to the correlations of the estimates, so
non-hierarchical methods are not able to handle many variables simultaneously. The
hierarchical models can be interpreted and handled more readily under the Bayesian
framework [30].
In the Bayesian framework, the prior distributions of parameters reflect the knowl-
edge before observing the data and the statistical inferences are based on the posterior
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distributions of parameters, which are proportional to the products of the prior dis-
tribution pi(Θ) and likelihood function L(data|Θ).
f(Θ|data) ∝ pi(Θ)× L(data|Θ) (1.15)
The posterior distributions will include all the current knowledge/information about
the parameters and can be updated as new information accumulates. The primary
objective of Bayesian inference is to explore the full posterior distributions of all
the parameters, which can be achieved by Markov chain Monte Carlo (MCMC) algo-
rithms. In certain circumstances, we may be interested in certain statistics that could
be obtained by more efficient computational algorithms [31]. For example, we may
want to find out the posterior modes of the parameters by maximizing the logarithm
of the products of the prior and likelihood:
log(f(Θ|data)) = log(L(Θ|data)) + log(pi(Θ)) + C (1.16)
where C is a constant irrelative to Θ. This is analogous to the penalized likelihood
model solution (1.10) with the logarithm of the prior log(pi(Θ)) as the penalty func-
tion. With certain priors, Bayesian hierarchical models can lead to the penalized
likelihood methods mentioned earlier. In Bayesian inferences, it is more comprehen-
sive to investigate the full posterior distributions rather than merely seek the posterior
modes as in the penalized likelihood methods.
The specification of priors in the hierarchical models is essentially important. Dif-
ferent types of priors could be proposed for dealing with high-dimensional data. Some
of the methods have been employed in the QTL mapping and association studies [22].
In the studies with a large number of predictors, it is reasonable to assume that many
of the predictors have weak or no effects on the traits. Therefore, for the regression
coefficients, we may set up the priors that assign low probabilities of being significant
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to the majority of the predictors.
Shrinkage Priors
One effective way for achieving the target of selecting the significant factors is to
assign shrinkage priors for the parameters. There are two commonly used shrinkage
priors for this Bayesian hierarchical modeling: double exponential (DE) and Student’s
t distribution [32]. Suppose that βj, j = 1 to J are the regression coefficients in the
generalized linear model, in which we want to obtain the posterior distributions by
(1.15). Their priors are
DE: pi(βj) = (λ/2)e
−λ|β|
t: pi(βj) = tvj(0, σ
2
j ) (1.17)
where λ and vj and σ
2
j are the tuning parameters to control the amount of shrinkage
in the hierarchical modeling. Both of the shrinkage priors could be translated to a
two-level hierarchical models, where the shrinkage priors are set up by controlling
the variances of the priors for the coefficients. The first level of the hierarchical
model assumes that the coefficients βj are normally distributed with mean 0 and
variance σ2j and the second level assumes that the variances follow some specific prior
distributions:
βj|σ2j ∼ N(0, σ2j )
σ2j |τj ∼ η(σ2j |τj) (1.18)
where η is the specific prior distribution and τj are the hyper-parameters. Then for
a DE prior:
η(σ2j |τj) = Gamma(1, τ 2j /2) (1.19)
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And for a t prior:
η(σ2j |τj) = Inverse− χ2(vj, τ 2j ) (1.20)
There are several advantages for these two-level hierarchical models. Due to the
conjugacy of certain priors pi2j , the Bayesian inferences could be easier to implement,
since the optimization is more readily to accomplish. By controlling the different
amount of shrinkage variances, some of the parameters ultimately shrink to zero.
Also, there is some flexibility in specifying the priors for the hyper-parameters in a
hierarchical structure.
Mixture Priors
The second popular class of priors assume two components in a single model: one
represents the parameters with null effects and the other with non-null effects. Here
we will describe two typical Bayesian mixture priors structure: ’Spike and Slab’ and
Stochastic Search Variable Selection (SSVS).
A Spike and Slab [33] [34] prior mixture structure assumes that the prior of each
parameter is a mixture of a diffuse distribution and a point mass at 0 as
βj|Ij, σ2j ∼ IjN(0, σ2j ) + (1− Ij)1∅ (1.21)
where 1∅ is a point mass at 0 and Ij is the binary variable indicating if the effect is
present or not in the model. In the second level, a Bernoulli distribution is assumed
for the indicators and a hyper prior is assumed for the variance components.
Ij ∼ Bernoulli(pj)
σ2j ∼ Inverse− χ2(vj, τ 2j ) (1.22)
So the variable selection performance such as sparseness can be controlled by the
specifications of hyper-priors by (1.22). Stochastic Search Variable Selection struc-
tures were proposed by George and McCullogh [35] [36]. Rather than assuming a
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point mass at zero as the ’Spike and Slab’ priors, SSVS applies a prior component
condensed at the ’Null’ effect part N(0, σ2j) as
βj|Ij, σ2j , σ2j ∼ IjN(0, σ2j ) + (1− Ij)N(0, σ2j) (1.23)
These mixture prior approaches have been applied in QTL mapping studies [37] and
[38]. In the following chapters, we choose to focus on the development of models with
SSVS, because the variances within the ’Null’ effect part may capture some effect
bias arising from genotyping errors or confounding due to study designs.
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2. Bayesian Variable Selection for Hierarchical
Gene-Environment and Gene-Gene Interactions
2.1 Motivation
2.1.1 Biological Background
Complex diseases are influenced by multiple genetic and environmental factors.
The factors may interact and are hard to directly discern. The advances in genome-
wide association studies (GWAS) have provided powerful tools to study the genetic
contributions to complex diseases [1]. During the past few years, a large number of
robust associations between chromosomal loci and complex diseases have been iden-
tified by GWAS. However, the genetic variants identified by GWAS only explain a
small proportion of the heritability of most diseases and it is speculated that gene-
gene and gene-environment interactions could explain some of the missing heritability
[5]. Moreover, typical applications of GWAS analysis do not study gene-gene and
gene-environment interactions. We therefore developed advanced statistical methods
jointly modeling interactions and main effects to address the problem to explaining
better disease heritability and causality.
Gene-gene and gene-environment interactions among risky factors have already
been widely investigated in genetics, genomics, evolution and epidemiology. The
term ’interaction’ has many meanings. Here we focus on the statistical definition of
interaction as a departure from additivity of the main effects. The genetic expression
level of certain genes can be inhibited or induced by certain environmental factors,
which causes a biological interaction that may result in a statistical interaction. Also,
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the environmental factors’ effects could be modified according to the effects from
genetic factors.
2.1.2 Statistical Background
Bayesian Variable Selection
Variable selection has been extensively studies in statistics. When we seek to
evaluate the effects of many potential variables and have a limited number of ob-
servations, finding the predictors that parsimoniously explain the variations in the
dependent variables is challenging. There are many statistical models that have been
proposed for variable selection. Here we focus on the Bayesian hierarchical mixture
model. In the Bayesian framework, we can view variable selection as identifying the
non-zero regression parameters based on the posterior distributions of the parameters.
Different priors have been considered for this variable selection purpose. A spike and
slab [33] prior mixture structure was proposed by assuming that the prior of each
parameter is a mixture of a diffuse distribution and a point mass at 0. These two
components in the priors represent the prior belief about an effect’s existence or not.
George and MuCulloch (1993, 1997) [35] [36] proposed the Stochastic Search Variable
Selection (SSVS) model that assumes the prior for each parameter as a mixture of two
distributions, both of which are typically centered at 0 but with different magnitudes
of variances for the corresponding normal density functions.
Hierarchical Interaction
For statistical modeling of interactions, there may be a hierarchical structure
among the predictors. For example, if we consider setting up a regression model with
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dependent variable Z and three independent variables X1, X2, X3, then the model
with all the two-way interactions will be
f(E(Y )) = α + β1X1 + β2X2 + β3X3 + γ12X1X2 + γ13X1X3 + γ23X2X3
where f(.) is the link function. In a usual statistical modeling approach, when in-
ferring each effect or variable selection, the main effect parameters are not treated
differently from interaction parameters, which means there is no constraint on the
parameter space for these two kinds of parameters. However, the resulting model can
be difficult to interpret. Moreover, usually if an interaction is present, the main ef-
fects will be nonzero. In practice, a statistical researcher commonly requires that the
interaction effects should be included with their corresponding main effects, otherwise
the resulting model tends to be rather unstable. In the statistical literature, Hamada
and Wu (1992) [39] first introduced the concept of hierarchical interaction that was
named ’Heredity principle’. There are two versions of hierarchical constraints on ef-
fects [13] [44]. Under the strong hierarchical constraint, for any two-way interaction
term to be included in the model, both of the main effects must also be included;
whereas under the weak hierarchical constraint, for any two-way interaction term to
be included in the model, one of the main effects must be included. In other words,
Strong Hierarchical Interaction: γ12 6= 0⇒ β1 6= 0 ∩ β2 6= 0,
Weak Hierarchical Interaction: γ12 6= 0⇒ β1 6= 0 ∪ β2 6= 0.
These effect constraints have been studies extensively in the variable selection
literature. Choi (2009) [40] and Jacob (2013) [41] imposed this constraint on the
popular variable selection approach Least Absolute Shrinkage and Selection Opera-
tor (Lasso). Yuan (2007, 2009) [42] [43] improved other original variable selection
approaches (LARS and Nonnegative Garrote) with this constraint. The Bayesian
model with this constraint was first introduced by Chipman (1996) [13]. In his paper,
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they proposed a hierarchical prior structure for modeling the interaction effects with
the constraint. But their approach does not explain explicitly the rationale of the
prior specifications. In this project, we specify the priors of the main effects and
interactions and incorporate them into the Bayesian mixture model we proposed.
2.2 Methodology
2.2.1 Classic Bayesian Hierarchical Model
Suppose we study n observations. We denote zi as the disease status (1 for positive,
0 for negative) with i = 1, ..., n. Let xij denote the number of minor alleles for the jth
SNP of ith observation, yik as the kth environmental exposure for ith observations.
In logistic regression, we will include the main effects of both gene and environment
as well as gene-environment and gene-gene interaction analysis as
zi ∼ Bernoulli(pi)
log
pi
1− pi = α +
∑
j
βjxij +
∑
k
γkyik +
∑
j
∑
k
θjkxijyik +
∑
j<l
ηjlxijxil
where pi indicates the probability of disease. α is the general intercept and exp(α) is
the baseline odds for the disease if we do not include any predictors in the model. βj
is the genetic effect and exp(βj) denotes the increase of odds with one minor allele
count increase. γk is the environmental effect for the kth exposure and exp(γk) de-
notes the increase of odds with the environmental exposure present in the model. θjk
denotes the gene-environment interaction effects between the jth SNP and the kth
environmental factor and ηjl denotes the interaction effect between jth and lth SNP.
Since the gene-gene products xijxil, j 6= l are internally symmetric, it is reasonable
to assume that ηjl = ηlj, therefore we index the parameters as j < l. For example,
when we consider 6 candidate SNPs with 1 candidate EXPs, 6 gene-environment in-
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teractions and 15 gene-gene interaction parameters will also be included in the model.
Then for each parameter, we shall assume normal priors for the parameters in the
regression:
βj ∼ N(0, σ2j )
γk ∼ N(0, σ2k)
θjk ∼ N(0, σ2jk)
ηjl ∼ N(0, σ2jl) (2.1)
On the next level, the hyperpriors are assumed for the variance components for each
parameter:
σ−2j ∼ Gamma(aj, bj)
σ−2k ∼ Gamma(ak, bk)
σ−2jk ∼ Gamma(ajk, bjk)
σ−2jl ∼ Gamma(ajl, bjl) (2.2)
These structures are from the conventional Bayesian hierarchical model for proposing
the priors for the parameters [12]. Recently, researchers have started to modify this
framework for the purpose of variable selection. Park and Casella (2008) [32] and Yi
(2009) [22] proposed the Bayesian Lasso model by proposing some common priors for
the parameters, by which the trivial parameters would be flattened out the model. In
this paper, we work on proposing different structures for the variances by assuming
the mixture components.
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2.2.2 Bayesian Mixture Model
Under the null hypothesis of no effects, we impose a prior distribution for each
parameter, while tiny variances imply a condensed mass distribution centered at 0:
βj ∼ N(0, σ2j)
γk ∼ N(0, σ2k)
θjk ∼ N(0, σ2jk)
ηjl ∼ N(0, σ2jl) (2.3)
Under the alternative hypothesis of nonzero effects, similar priors with larger variances
are given as:
βj ∼ N(0, σ2j )
γk ∼ N(0, σ2k)
θjk ∼ N(0, σ2jk)
ηjl ∼ N(0, σ2jl) (2.4)
Motivated by the Stochastic Search Variable Selection framework [35] [36], a mix-
ture model is proposed here for the modeling of the effects in the logistic regression
model. Therefore, the priors with the indicators can be written as:
βj ∼ N(0, Ijσ2j + (1− Ij)σ2j)
γk ∼ N(0, Ikσ2k + (1− Ik)σ2k)
θjk ∼ N(0, Ijkσ2jk + (1− Ijk)σ2jk)
ηjl ∼ N(0, Ijlσ2jl + (1− Ijl)σ2jl) (2.5)
Each of the indicators in the model follows a Bernoulli distribution as:
21
Ij ∼ Bernoulli(pij)
Ik ∼ Bernoulli(pik)
Ijk ∼ Bernoulli(pijk)
Ijl ∼ Bernoulli(pijl) (2.6)
2.2.3 Bayesian Mixture Model for Hierarchical Interactions
Under the strong hierarchical interaction model, we propose a scheme to describe
the relationships among the indicators of these parameters as
pijk = Ij × Ik × pisjk
pijl = Ij × Il × pisjl (2.7)
where pisjk and pi
s
jl are the conditional prior probability of the indicator for interaction
effects being non-null given both the main effects being non-null under the weak
hierarchical interaction model. For each conditional prior probabilities, we assume
that
pisjk = min(pij, pik)
pisjl = min(pij, pil) (2.8)
Of course, other frameworks for the priors for these conditional priors can be pro-
posed. By assuming the strong hierarchical effects model, the prior probability should
be more consistent with each of the main effects.
Under the weak hierarchical interaction model, we propose a scheme for describing
the relationship between the interaction effects and the main effects as
pijk = (Ij + Ik − Ij ∗ Ik)× piwjk
pijl = (Ij + Il − Ij ∗ Il)× piwjl (2.9)
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where piwjk and pi
w
jl are the conditional prior probability of the indicator for interaction
effects being non-null given both the main effects being non-null under the strong hi-
erarchical interaction model. For each of the conditional prior probability, we assume
that
piwjk = min(pij, pik)×
Ijpij + Ikpik
pij + pik
piwjl = min(pij, pil)×
Ijpij + Ilpil
pij + pil
(2.10)
So when both of the corresponding main effects for the gene-environment interactions
are present in the model, we denote the conditional probability as piw11jk = min(pij, pik);
When both of the main effects are missing in the model, piw00jk = 0;
When Ij = 0 and Ik = 1, we denote the conditional prior probability as
piw01jk = min(pij, pik)×
pik
pij + pik
(2.11)
When Ij = 1 and Ik = 0, we denote the conditional prior probability as
piw10jk = min(pij, pik)×
pij
pij + pik
Therefore, piw00jk ≤ (piw01jk , piw10jk ) ≤ piw11jk and piw01jk /piw10jk = pik/pij. These structures
reflect our belief that the interaction terms will be more likely to be non-null in the
model when both main effects are present than one of the main effect is missing. Also,
larger main effects are more likely to bring appreciable interactions than small main
effects. As mentioned in Jacob (2013) [41], Cox(1984) [9] first brought up this model
constraint in the statistical literature. Our Bayesian model will naturally take into
account these properties in the prior setups. It would be rather difficult to consider
all these constraints in the frequentist model framework.
In our models, we fix the two mixture variances components for each of the pa-
rameters. Usually the total number of the factors considered is large, so it may be
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possible to estimate the variances from the data. In logistic regression, for the main
effect parameters, exp(βj) and exp(γk) correspond to the relative odds for the disease
when only including these individual parameters are included in the model. There-
fore, we fix the variance components by restricting their confidence interval within a
prespecified range of disease odds. So under the null hypothesis, we assume the 95%
confidence interval will be e1.96σj = e±0.05 and e1.96σk = e±0.05. These specification
will provide that the odds will be within interval (0.951, 1.051). Similarly, we assume
the same variances for the null-component of the interaction effects. Under the alter-
native hypothesis, we set up the variances components by restricting the odds within
a certain range. We assume the 90% confidence interval of odds would be at (1
3
, 3) for
genetic main and gene-gene Interaction effects and (1
4
, 4) for environmental exposure
main and gene-environment interaction effects. Therefore, we set the values for the
hyper priors for the variances as:
σ2j = σ
2
k = σ
2
jk = σ
2
jl = 0.00065
σ2j = σ
2
jl = 0.446
σ2k = σ
2
jk = 0.710 (2.12)
2.2.4 Posterior Inference
We have provided the prior structures for the Bayesian mixture model for the
Hierarchical Interaction Model. The full posterior distribution of the parameters
given the data would be
f(α, β, γ, θ, η, Iβ, Iγ, Iθ, Iη|data) ∝ f(data|α, β, γ, θ, η, Iβ, Iγ, Iθ, Iη)×
f(α)f(β|Iβ)f(γ|Iγ)f(θ|Iθ)f(η|Iη)× f(Iβ)f(Iγ)f(Iθ|Iβ, Iγ)f(Iη|Iβ) (2.13)
where β is the parameter vector for genetic main effects, γ for environmental exposure
main effects, θ for gene-environment interaction effects and η for gene-gene Interaction
24
−1.0 −0.5 0.0 0.5 1.0
0
5
10
15
Parameter Values
De
ns
ity
Null (.00065)
non−Null (.446)
non−Null (.710)
Figure 2.1.: Two components for the mixture priors of parameters. ’Null (.00065)’
corresponds to the 95% C.I. of Odds (.951,1.051), ’Non-Null(.446)’ corresponds to 90%
C.I. of Odds (1/3,3) and ’Non-null(.771)’ corresponds to 90% C.I. of Odds (1/4,4).
effects. Also, Iβ, Iγ, Iθ and Iη are the corresponding indicator vectors. We apply
WinBUGS to implement the Markov chain Monte Carlo algorithms for the posterior
inferences of the parameters, such that the posterior samples of parameters can be
drawn [45].
2.3 Empirical Results
In this section, we use simulation studies to present the efficacy of the proposed
approach and to compare the results with the model that does not consider the hier-
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archical interactions in the models. Certainly, the efficacy of the models will depend
on the true model generating the data. To provide broad evaluations, we conducted
three simulation studies to cover a range of possible scenarios in practice. We propose
three different studies:
Study I: 6 genetic factors (SNP), 1 environmental exposure factor (EXP) and 6
gene-environment Interaction factors (GEI)
Study II: 50 SNPs, 1 EXP and 50 INTs
Study III: 6 SNPs, 1 EXP, 6 GEI and 15 pairwise gene-gene Interaction factors (GGI)
We compared the performance of four models based on Bayesian mixture models.
Wakefield (2010) [46] proposed a model structure for the interaction that includes
the interaction term when both of the main effects are present in the model as:
Ijk = Ij × Ik. We will denote this as ’effect enforce’ model as in Chipman et al.
(2006) [47]. Also we considered the independent model which does not impose any
constraint on the relationships between the interaction parameters and the main ef-
fect parameters. Then we will consider the proposed hierarchical interaction models:
Strong hierarchical model and weak hierarchical model.
In the simulation studies, we compared the four models in terms of the prediction
accuracy and variable selection performance. In the 3 studies, we generated 100 repli-
cates with 1000 cases and 1000 controls for each scenario under the same parameters.
For measuring the prediction accuracy, we compare the prediction errors (PE) on a
test set with 20000 cases and 20000 controls by
PE =
1
N
N∑
i=1
|ytesti − pˆi| (2.14)
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where N = 40000 here, ytesti is the disease status of ith patient and pˆi is the estimated
probability of having the disease by
pˆi =
1
1 + exp(−(Li) (2.15)
where Li is the linear predictor for the ith observation. We will also add the results
from the traditional logistic regression as the benchmark for comparison on the pre-
diction performance.
We also compare the variable selection performance among the four models. Since
our main interest in the project is to improve the modeling of the interaction effects,
we focused on evaluating the capacity of the models for recovering the non-null gene-
environment interaction and gene-gene interaction while controlling the false discov-
ery of the non-null effects. In each scenario, we measured the sensitivity which is
the proportion of the non-null effects being selected, and the specificity, which is the
proportion of the null effects not being selected.
There is also a criteria in variable selection studies to control the total number
of parameters being selected. For example, in Lasso studies by changing the penalty
parameter λ, the number of the parameters included in the model will change ac-
cordingly. Also, in forward/backward stepwise selection, we need to directly specify
the total number of parameters we want to include in a model. In Bayesian variable
selection study areas, the median model decision rule is a typical approach. It will
select all the covariates in the model with P (I = 1|data) ≥ 0.5.
2.3.1 Study I
We include 6 additive genetic factors (SNP) and 1 environmental factor (EXP) to
simulate the independent variables for generating the data. We focused on the study
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of case-control qualitative datasets with 1000 cases and 1000 controls in all settings.
For simulating the dataset, we fixed the prevalence of the EXP and the minor allele
frequency (MAF) of the SNPs and set the effect parameters corresponding to the
odds of disease. The MAF of the non-null SNP is fixed as 0.1 and non-null SNP as
0.3. The environmental exposure factor is fixed at 0.1. As shown in Table 1, we are
considering 8 different scenarios for the interaction studies. In all scenarios, we as-
sumed the odds for the non-null genetic factor was 1.25 and for the non-null exposure
factor was 1.5, which corresponds to the parameter values in Table 1.
The 8 scenarios reflect the conditions that are frequently encountered in practical
gene-environment interaction studies. Scenario 1 is the ’Null’ model that does not
include any significant effect factors. Scenario 2 includes a non-null environmental
factor without any genetic main or interaction effects. In scenario 3, the environ-
mental factor is significant and it also has a significant gene environment interaction
SNP 6. In scenario 4 and 5, the environmental factor is absent while an effect from
SNP 6 is present. And a non-null gene-environment interaction between SNP 6 and
the exposure is absent in scenario 4 and present in scenario 5. In scenario 6, there is
one genetic main effect and one environmental effect present without any significant
interaction effects. In scenario 7, the interaction between SNP 6 and the environmen-
tal factor exists as well as a corresponding main effect. In scenario 8, one additional
gene environment interaction effect was added to the model compared with scenario
7, including a main effect that is not significant.
Figure 2.2 to Figure 2.11 show the variable selection performance of the four
Bayesian models. Compared with the independent model, the other three models
tend to select main effects more often than interaction effects. In scenario 1, the
three hierarchical models control the probability of selecting the interaction effects to
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be under 0.5. In scenario 2, the strong hierarchical model has the largest probability
of selecting the non-null environmental factor. In scenario 3, the strong hierarchi-
cal model has higher probability of selecting the non-null environmental factor while
failing to select the interaction effects. The weak hierarchical model has a similar
performance to the independent model, inferior to the strong hierarchical model. In
scenario 4, all the models perform similarly in selecting the non-null genetic effect.
The effect enforce, strong hierarchical and weak hierarchical model perform very well
in controlling the false positive discovery of the null effect for the environmental factor
and interaction effects. In scenario 5, we observe a similar phenomenon as scenario
3 for the hierarchical model’s failure to detect the interaction effects. In this case,
the weak hierarchical model performs better than the strong hierarchical model. In
scenario 6, all the three hierarchical models perform better than the independent
model on the controlling the false positive discovery of the non-null interactions. In
scenario 7, the strong hierarchical model has a larger probability of selecting the non-
null environmental factor but did not control well the false discovery of interactions.
The effect enforce model and the weak hierarchical model controlled the number of
false positive discoveries better for this scenario. In scenario 8, we observed a sim-
ilar pattern to scenario 7 for detecting the interactions. Scenario 9’s setup violates
the hierarchical assumption for the interaction effect. In this scenario, we observe
that the independent model identifies the non-null interaction effect while the others
do not work very well. However, the independent model could not identify well the
environmental factor effect. The weak hierarchical model performs similarly as the
independent model. In scenario 10, there is one non-null interaction effect and the
other factors are null. The independent model outperforms the other models. This
is mainly because the truth violates the hierarchical assumption and the interaction
effect is non trivial.
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Figure 2.12 and Figure 2.13 show the prediction performance of the five models
in each scenario. The frequentist logistic regression generates the largest prediction
error when compared with the other Bayesian models. In general, the strong hierar-
chical model has the lowest level of prediction error. Scenario 3, 5 and 8 violate the
strong hierarchical assumption. In these 3 scenarios, the strong hierarchical model
surprisingly still outperforms the others. In scenario 5, there is one non-null genetic
factor and the environmental factor is also non-null, while the interaction effect is
null. In this scenario, the effect enforce model, strong hierarchical model and weak
hierarchical model outperform the independent model, because these three models
favor the main effect. In scenario 9, the independent model outperforms the other
models because of the capability of finding out interactions without constraints on
main effects.
30
S
N
P
E
x
p
os
u
re
G
E
In
te
ra
ct
io
n
P
at
te
rn
β
1
β
2
β
3
β
4
β
5
β
6
γ
1
θ 1
θ 2
θ 3
θ 4
θ 5
θ 6
S
ce
n
ar
io
1
0
0
0
0
0
0
0
0
0
0
0
0
0
n
u
ll
S
ce
n
ar
io
2
0
0
0
0
0
0
.4
05
0
0
0
0
0
0
ex
p
on
ly
S
ce
n
ar
io
3
0
0
0
0
0
0
.4
05
0
0
0
0
0
.4
05
ex
p
&
in
t
S
ce
n
ar
io
4
0
0
0
0
0
.2
23
0
0
0
0
0
0
0
S
N
P
on
ly
S
ce
n
ar
io
5
0
0
0
0
0
.2
23
0
0
0
0
0
0
.4
05
S
N
P
&
in
t
S
ce
n
ar
io
6
0
0
0
0
0
.2
23
.4
05
0
0
0
0
0
0
S
N
P
&
ex
p
S
ce
n
ar
io
7
0
0
0
0
0
.2
23
.4
05
0
0
0
0
0
.4
05
S
N
P
&
ex
p
&
in
t
S
ce
n
ar
io
8
0
0
0
0
0
.2
23
.4
05
0
0
0
0
.4
05
.4
05
S
N
P
&
ex
p
&
in
t∗
S
ce
n
ar
io
9
0
0
0
0
0
.2
23
0
0
0
0
0
.4
05
0
S
N
P
&
in
t∗
∗
S
ce
n
ar
io
10
0
0
0
0
0
0
0
0
0
0
0
0
.4
05
in
t
on
ly
Table 2.1: Parameter setups for Study I
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Figure 2.2.: Scenario 1 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.3.: Scenario 2 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.4.: Scenario 3 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.5.: Scenario 4 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.6.: Scenario 5 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.7.: Scenario 6 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.8.: Scenario 7 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
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Figure 2.9.: Scenario 8 in Study I. The boxplots of each factor being selected in 100
replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE interaction
effects
39
Strong Hierarchy
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e i
Weak Hierarchy
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e i
Effect Enforce
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e i
Independent
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e i
Figure 2.10.: Scenario 9 in Study I. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE
interaction effects
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Figure 2.11.: Scenario 10 in Study I. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’i’ refers to 6 GxE
interaction effects
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Figure 2.12.: Prediction performance for each model in each scenario of study I.
’ind’:independent, ’enf’: effect enforce, ’str’: strong hierarchical, ’wea’: weak hierar-
chical, ’fre’ frequentist logistic regression.
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Figure 2.13.: Prediction performance for each model in each scenario of study I.
’ind’:independent, ’enf’: effect enforce, ’str’: strong hierarchical, ’wea’: weak hierar-
chical, ’fre’ frequentist logistic regression.
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SNP Exposure GE Interaction
β48 β49 β50 γ1 θ47 θ48 θ49 θ50
Scenario 1 .223 .223 .223 .405 0 0 0 0
Scenario 2 .223 .223 .223 .405 0 0 0 .405
Scenario 3 .223 .223 .223 .405 0 .223 .223 0
Scenario 4 .223 .223 .223 .405 0 .223 .223 .405
Scenario 5 .223 .223 .223 .405 .223 0 0 0
Table 2.2: Parameter setups for Study II
2.3.2 Study II
We simulate 50 SNPs with only the additive effects and 1 EXP to simulate the
data. Here, we only consider the genetic and environmental main effects as well as
gene environment interaction effects. This study imitate the real practice in which
we wish to find out the predisposing SNPs and also the positive interactions among
the SNP and environmental factor. In this type of study, the environmental factor is
usually already confirmed as an non-null factor, so here in all scenarios we simulate
the environmental factor having non-null effects. The MAF for SNP and frequency
for EXP are set the same as in Study I.
In all scenarios, we assume 3 non-null genetic effects among 50 SNPs and one
non-null effect. In scenario 1, there is no gene-environment interaction. In scenario
2, there is one non-null larger interaction effect. In scenario 3, two relatively smaller
interaction effects exist. In scenario 4, we assume there are non-null interaction effects
with with different values. In scenario 5, there is one small interaction effect which
corresponds to the null SNP. Here we still want to examine the prediction and vari-
able selection performance of the proposed models. Due to the same setting for the
44
main effects, here we will only show the variable selection performance on selecting
the interaction effects. The results also have shown the results on the interaction part
are very similar to each other. The results are also based on 50 replicates in each
scenario. Since we assume that the environmental factors are non-null in the model,
the weak hierarchical model is the same as the independent model. The existence
of the non-null interaction effect will not depend on the corresponding genetic factors.
So as shown in Figure 2.14, the strong hierarchical model does best among the
four models on the prediction performance. This is because the strong hierarchical
model favors the main effects more than the interaction effects. In Figure 2.15, in all
scenarios, the strong hierarchical model has a superior result for controlling the false
positive. Although the power of detecting the interaction is limited by the feature
of model, the capacity of controlling false positive make up for its inferior ability to
detect non-null effects. In scenarios 2, 3 and 4, the effect enforce model outperforms
the other models in selecting the true positive interaction effects, while controlling
the false positive comparably to the strong hierarchical model. This is because the
model partially or fully matched the assumption in the truth of the simulated data.
In this scenario, the non-null interaction is present without the corresponding genetic
main effect. Then we observe that the effect enforce model performs poorly as the
strong hierarchical model on detecting the non-null interaction.
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Figure 2.14.: Prediction performance for each model in each scenario of study II.
’ind’:independent, ’enf’: effect enforce, ’str’: strong hierarchical, ’wea’: weak hierar-
chical, ’fre’ frequentist logistic regression.
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Figure 2.15.: Variable selection performance for each model in each scenario of study
II. ’ind’:independent, ’enf’: effect enforce, ’str’: strong hierarchical, ’wea’: weak hier-
archical, ’fre’ frequentist logistic regression.
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SNP Exposure GE Interaction GG Interaction
β5 β6 γ1 θ6 τ1 τ14 τ15
Scenario1 .223 .223 .405 .405 0 0 0
Scenario2 .223 .223 .405 .405 0 0 .223
Scenario3 .223 .223 .405 .405 0 .223 0
Scenario4 .223 .223 .405 .405 .223 0 0
Table 2.3: Parameter setups for Study III
2.3.3 Study III
In Study III, we further incorporate the gene-gene interaction effects into the com-
plete model based on Study I. In total we have 6 genetic main effects, 1 environmental
factor, 6 gene-environment interactions and 15 pairwise gene-gene interactions. In this
study, we consider 4 different scenarios by changing the gene-gene interaction param-
eter values while fixing the other effects. The true parameter values are presented as
in Table 2.3.
In scenario 1, the strong hierarchical model assigned all the null GxG interaction
effects to have a lower posterior probability and yielded a better selection of the non-
null main effects than the other models. The independent model performed best at
identifying the GxE interaction. In scenario 2, the GxG interaction between SNP 5
and SNP 6 is set as non-null. The independent model performs well on identifying
the GxG interaction effect. However, it performed worse on finding the non-null
genetic effects for SNP 5 and SNP 6. In scenario 3, which partially violates the
hierarchical structure, shows the similar phenomenon as scenario 2. Compared with
the independent model, the strong hierarchical model is good at identifying the main
effect. The weak hierarchical model performs similarly as the independent model and
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the effect enforce model similarly as the strong hierarchical model. In scenario 4,
the non-null GxG interaction corresponds to null genetic main effects at SNP 1 and
SNP 2. So here we observed that the independent model could identify the significant
interaction while the other models failed. This is because that the independent model
dose not put any constraint on the hierarchical structure. Also, due to the hierarchical
structure, the strong hierarchical, weak hierarchical and effect enforce model tend to
have a larger probability of including the corresponding SNPs. When we compared
the prediction performances in these four scenarios, the strong hierarchical mode
performed best in overall. In scenario 4, the independent model perform similarly
to the strong hierarchical model. The strong hierarchical model detected the non-
null main effects to make up for its inferior ability to detect the interactions and the
tendencies to include the null main effects.
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Figure 2.16.: Scenario 1 in Study III. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’ss’ refers to 15 GG
interaction effects
50
Strong Hierarchy
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e ss
Weak Hierarchy
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e ss
Effect Enforce
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e ss
Independent
p o
s t
e r
i o
r  i
n c
l u
s i
o n
 p
r o
b a
b i
l i t y
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
s e ss
Figure 2.17.: Scenario 2 in Study III. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’ss’ refers to 15 GG
interaction effects
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Figure 2.18.: Scenario 3 in Study III. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’ss’ refers to 15 GG
interaction effects
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Figure 2.19.: Scenario 4 in Study III. The boxplots of each factor being selected in
100 replicates. ’s’ refers to the 6 SNPs. ’e’ refers to EXP and ’ss’ refers to 15 GG
interaction effects
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Figure 2.20.: Prediction performance for each model in each scenario of study III.
’ind’:independent, ’enf’: effect enforce, ’str’: strong hierarchical, ’wea’: weak hierar-
chical, ’fre’ frequentist logistic regression.
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2.4 Real Data Examples
2.4.1 Lung Cancer
We applied our proposed Bayesian methods and the independent model to the
data from the International Lung Cancer Consortium. The data include 17 different
studies in 13 countries. For illustration of the model, we focused on 6 SNPs in 3
regions: rs2736100 and rs402710 at 5p15, rs2256543 and rs4324798 at 6p21, and
rs16969968 and rs8034191 at 15q25. The data we applied include 8867 participants
with complete data. Among all the participants, there were 5,217 controls and 3,650
cases. In the case group, there were 2,434 males and 1,216 females and 3,378 were
smokers. In the control group, there were 3,642 males and 1,575 females and 3,703
were smokers. We include sex as a covariate and the smoking indicator as the envi-
ronmental factor. In the model, we wanted to detect the genetic and environmental
main effects and the gene-gene interaction and gene-environment interactions simul-
taneously.
Figure 2.21 shows the result for running the three different models on the data
set. Since the six SNPs have been tested to cause the cancer in prior studies [48],
we include them with the prior of each SNP being significant with probability 0.9.
Also, for the gene-environment and gene-gene interactions we assume the prior for
the effects being significant with probability 0.5. There were 6 SNPs, 1 EXP, 6 gene-
environment interaction and 15 pairwise gene-gene interaction. In the graph, we
found that there were no gene-gene interactions that can be regarded as significant.
In the main effects part, all the models identified the smoking factor with probability
1 and the independent models identified all the SNPs with probability larger than
0.5. The strong hierarchical model identify rs402710 as the most significant factor
with the other two non-null SNPs. The two SNPs at 6p21 are substantially non-
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significant compared with the SNPs found at the other regions. The three models
also do not identify obvious gene environment interactions. The weak hierarchical
model only identified the interaction between rs16969968 and the smoking. Also,
the hierarchical model lower the probability of interaction between rs2256543 and
smoking. These two interaction worth mentioning.
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Figure 2.21.: Real data results for the lung cancer study.
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2.4.2 Cutaneous Melanoma
We also applied our models in the cutaneous melanoma studies. We first selected
24 SNPs that have been found previously in GWAS. It is also well known that eye
color correlates with certain genetic factors. So in this study, we want to find out the
interaction between genetic factors and eye color that can relate to the occurrence
of cutaneous melanoma. After removing the data with missing values, the data were
composed with 929 cases and 1,024 controls. There are five different colors for eyes
as in Table 2.4 . We coded the color factor into 2 dummy variables which represent
the comparisons between 3 level of eye colors (blue/grey, brown and green/hazel).
Green and heel colors were combined because they have similar hues and similarly
blue and grey were combined because grey eyes are are and of similar grade in hue to
blue. We included 24 SNPs as the candidate genetic factors: rs1015362, rs1042602,
rs10757257, rs10830253, rs12896399, rs12913832, rs1335510, rs1393350, rs1408799,
rs16891982, rs17305573, rs1805007, rs1806319, rs1847142, rs1885120, rs2218220,
rs2284063, rs28777, rs4911414, rs4911442, rs6001027, rs7023329, rs910873 and
rs935053.
Figure 2.22 shows the variable selection results by the three Bayesian models.
Totally we are considering 24 genetic factors, 2 environmental factors and 48 gene
environment interactions. The interaction between rs12913832 and the eye color has
been found significant in the study of Amos et al. (2011) [49]. The hierarchical model
also finds the interaction between rs17305573 and the eye color. For the other inter-
action terms, the posterior probability does not exceed 50%, indicating no evidence
of an interactions. The Independent model also tends to generate higher probability
for the interactions. The hierarchical model successfully controlled the probability of
false positive discovery that enable us to focus on the significant interactions.
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Eye color Case Control Total
Blue 396 331 727
Grey 12 18 30
Brown 189 312 501
Green 150 164 314
Hazel 182 199 381
Total 929 1,024 1,953
Table 2.4: The distribution of study samples with different eye colors in the case-
control study
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2.5 Discussion
In this project, we introduced the Bayesian mixture model for modeling the gene-
gene and gene-environment interactions simultaneously. Compared with the tradi-
tional logistic regression model, the Bayesian model showed good performance in sim-
ulation studies on parameter estimation and variable selection. Traditionally, there
is no constraint on the modeling of the main effects and higher order interactions in
the same model. When several genetic and environmental factors are jointly mod-
eled, there will be a possibly huge number of potential interactions, which will make
model fitting and variable selection difficult. Although the hierarchical approaches
we studied have been developed in the statistical machine learning literatures, there
is a clear need for extending the model application into the genetic studies. Several
articles Cheongeun (2003), Wakefield (2010) [46] [50] mentioned applying a hierarchi-
cal constraint. Our research provided a systematic approach to setting up the priors
among the variables to impose a hierarchical constraint.
Here we only considered case-control analysis, but the model is readily applied to
continuous outcome studies. Due to the computational burden for the Bayesian anal-
ysis, we limit the total number of genetic and environmental factors in the model.
So the proposed model could be recognized as the second step analysis after the
GWAS studies, from which we can filter the interesting genetic factors for further
explorations. Another important aspect for the Bayesian modeling is the specifica-
tion of the priors. In our approach, we provided fixed values for the two variance
components for the prior distributions of the main effects and interactions. For the
factor indicators, we assigned non-informative prior with 0.5 probability for each of
the indicators. As shown in the lung cancer real data analysis, when we already know
that some environmental factors are directly related with the outcome, then we can
specify a very high prior probability for that indicator. In practice, without further
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information we may set the prior probability as the proportion of the factors that we
have prior belief will be associated with disease risk.
2.6 Appendix: Prior Elicitations by Bayesian Model Averaging
Assumption and Notation
In the previous sections, we introduced the Bayesian mixture methods. The priors
for the indicators were fixed a priori. In practice, we may have prior information on
the probability for each factor being non-null among all the considered factors. In
this Appendix, we tried to apply a Bayesian model averaging approach to elicit the
priors when evaluating gene and environment main effects and interactions in the
epidemiological case-control studies. This approach allows some uncertainties on the
specification of the priors, which will result in a more robust model.
We denote xi(i = 1, 2, ..., N) as the disease status (1 positive, 0 negative) for the
ith patient. Further, we denote ysi (s = 1, 2, ..., S) as the minor allele count (0,1,2) for
SNP s of patient i; zei (e = 1, 2, ..., E) as the environmental exposure e of patient i (1
exposed, 0 non-exposed).
Basic Modeling
We use a regression model to include both main and interaction effects for the ith
patient by
logit(pi) = α +BYi + ΓZi + Θ(Yi ⊗ Zi)
where pi indicates the probability of disease, α is the general intercept, Yi = [y
1
i , ..., y
S
i ]
T ,
Zi = [z
1
i , ..., z
E
i ]
T , and B = [β1, ..., βS], Γ = [γ1, ..., γE], Θ = [θ11, θ12, ..., θSE]. ⊗ is
a Kronector operator. Also, we denote βs, γe as the main effects of gene and envi-
62
ronment and θse as the interaction effect. Note that here we only consider the one
by one (G × E) interactions, whereas consideration of higher order interactions(e.g.
G×G× E) is possible by the extension of our models.
Hierarchical Mixture
We put the posterior inference of parameters into two stages:
1st stage. Under the null hypothesis of no effects, we impose a prior distribu-
tion for each parameter, where small variances σ2s , σ
2
e , σ
2
se imply a condensed mass
distribution centred at 0:
βs ∼ N(0, σ2s)
γe ∼ N(0, σ2e)
θse ∼ N(0, σ2se)
Under the alternative hypothesis of effects existing, similar priors with larger variances
(AKA: widespread distributed)are given as:
βs ∼ N(0, σ2s)
γe ∼ N(0, σ2e)
θse ∼ N(0, σ2se)
In Conti (2003) [51] and Wakefield (2010) [46], a mixture model indicator approach is
introduced for the modeling of testing of effects in their models. Similarly the priors
with indicators can be written as:
βs ∼ N(0, ISs σ2s + (1− ISs )σ2s)
γe ∼ N(0, IEe σ2e + (1− IEe )σ2e)
θse ∼ N(0, ISEse σ2se + (1− ISEse )σ2se)
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where, if ISs , I
E
e , I
SE
se = 1, we will reject the null hypothesis and confess the existence
of effects and Vice Versa. We propose that if at least one of ISs = 1 and I
E
e = 1
suffices, there could exist ISEse = 1. This reflects our belief that higher order ef-
fects(interactions) exist if at least one of the one lower order effects exists. Then, we
can simplify the interaction effect parameters as:
θse ∼ N(0, [1− (1− ISs )(1− IEe )]σ2se + (1− ISs )(1− IEe )σ2se)
This corresponds to
P (ISEse = 1|ISs , IEe ) =

p00 = 0 I
S
s = I
E
e = 0
p01 = 1 I
S
s = 0, I
E
e = 1
p10 = 1 I
S
s = 1, I
E
e = 0
p11 = 1 I
S
s = I
E
e = 1
As noted in Chipman (1996) [13], the higher-order interaction effects are always not
independent from the lower order effects. It satisfies p00 ≤ min{p01, p10} ≤ p11, As
example shown in their model, given P (ISs = 1) = 0.25 and P (I
E
e = 1) = 0.25,
P (ISEse = 1|ISs , IEe ) =

0.01 ISs = I
E
e = 0
0.1 ISs = 0, I
E
e = 1
0.1 ISs = 1, I
E
e = 0
0.25 ISs = I
E
e = 1
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However, the authors did not explicitly explain the rationale for selecting the param-
eters. In Wakefield (2010) [46], it is modeled as
P (ISEse = 1|ISs , IEe ) =

p00 = 0 I
S
s = I
E
e = 0
p01 = 0 I
S
s = 0, I
E
e = 1
p10 = 0 I
S
s = 1, I
E
e = 0
p11 = 1 I
S
s = I
E
e = 1
Or we may release the dependency between main effects and interactions, by setting
P (ISEse = 1|ISs , IEe ) =

p00 = pi
S
s pi
E
e I
S
s = I
E
e = 0
p01 = pi
S
s pi
E
e I
S
s = 0, I
E
e = 1
p10 = pi
S
s pi
E
e I
S
s = 1, I
E
e = 0
p11 = pi
S
s pi
E
e I
S
s = I
E
e = 1
2nd stage. Priors are given to the mixture indicators respectively:
ISs ∼ Bin(piSs )
IEe ∼ Bin(piEe )
Even when both main effects of each SNP × Exposure pair exist, the interaction
effect still can be missing. To solve this, the variances of interaction effects can be
proposed randomly inverse gamma distributed as:
σ2se ∼ IG(ase , bse)
σ2se ∼ IG(ase, bse)
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Prior Structure
Hinted by Chipman (2006) [47], we propose to use the priors structure:
P (ISEse = 1|ISs , IEe ) =
ISs ∗ piSs + IEe ∗ piEe
2
+
This relates to:
P (ISEse = 1|ISs , IEe )

p00 = 0 I
S
s = I
E
e = 0
p01 =
piEe
2
ISs = 0, I
E
e = 1
p10 =
piSs
2
ISs = 1, I
E
e = 0
p11 =
piSs +pi
E
e
2
ISs = I
E
e = 1
Bayesian Model Averaging
The Bayesian Model Averaging has been applied in several statistical models [52]
[53]. Here we modify the model by incorporating several competing candidate priors
we called Module’s for piSs , pi
E
e . The K Modules are:
(pi
S(1)
1 , ..., pi
S(1)
S , pi
E(1)
1 , ..., pi
E(1)
E )
...
(pi
S(k)
1 , ..., pi
S(k)
S , pi
E(k)
1 , ..., pi
E(k)
E )
...
(pi
S(K)
1 , ..., pi
S(K)
S , pi
E(K)
1 , ..., pi
E(K)
E )
We denote each Module k as Mk. Then the likelihood function under Mk and param-
eters A(k) will be:
L(D|A(k),Mk) =
N∏
i=1
{pi(k)}yi{1− pi(k)}1−yi
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where
pi(k) =
eα(k)+B(k)Yi+Γ(k)Zi+Θ(k)(Yi⊗Zi)
1 + eα(k)+B(k)Yi+Γ(k)Zi+Θ(k)(Yi⊗Zi)
The posterior model probability of Mk is given by
pr(Mk|D) = L(D|Mk)pr(Mk)∑K
k=1 L(D|Mk)pr(Mk)
We assume the Modules are equally possible a priori with pr(Mk) = 1/K and
L(D|Mk) is the marginal likelihood of model Mk,
L(D|Mk) =
∫
L(D|A(k),Mk)f(A(k)|Mk)dA(k)
in which, f(A(k)|Mk) corresponds to prior Modules with:
IS(k)s ∼ Bin(piS(k)s )
IE(k)e ∼ Bin(piE(k)e )
And the full expression of all parameters included in f(A(k)|Mk) is:
s=S,e=E∏
s=1;e=1
f(βs(k), γe(k), θse(k)|IS(k)s , IE(k)e , σ2se(k), σ2se(k))
×f(IS(k)s )× f(IE(k)e )× f(σ2se(k))× f(σ2se(k))× f(α(k))
where we impose a normal prior for α(k). Therefore, the posterior density of param-
eters will be
f(A|D) =
K∑
k=1
f(A|Mk, D)pr(Mk|D)
The BMA estimates Aˆ for the parameters of main effects and interactions will be
based on the model averaging,
E(A|D) =
K∑
k=1
E(A(k)|Mk, D)pr(Mk|D) ≈
K∑
k=1
Aˆ(k)pr(Mk|D) := Aˆ
by which, Aˆ(k) is the unbiased estimator of E(A(k)|Mk, D) (Newton, 1997) [55] and
V ar(A|D) = {
K∑
k=1
(V ar(A(k)|Mk, D) + (E(A(k)|Mk, D))2)pr(Mk|D)} − (E(A|D))2
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≈ {
K∑
k=1
(V ar(A(k)|Mk, D) + (Aˆ(k))2)pr(Mk|D)} − Aˆ2
≈ {
K∑
k=1
( ˆσ2A(k) + (Aˆ(k))
2)pr(Mk|D)} − Aˆ2 := σˆ2A
where ˆσ2A(k) is the unbiased estimator of V ar(A(k)|Mk, D) and A(k) follows
f(A(k)|Mk, D) =
f(D,A(k)|Mk)
f(D|Mk) =
L(D|A(k),Mk)f(A(k)|Mk)∫
L(D|A(k),Mk)f(A(k)|Mk)dA(k)
which we will sample from by Markov chain Monte Carlo methods via R compatible
free software WinBUGS [45].
Numerical Solution
The computation process is as follows:
Step 1 Under each Mk, use MCMC to generate a whole sample set denoted by
Aj(k)for all parameters A(k) in jth iteration of the simulation.
Step 2 After obtaining all samples Aj(k) (j = 1, ..., J), calculate the values of
L(D|Aj(k),Mk). Approximate the marginal likelihood of L(D|Mk) by
{ 1
J
J∑
j=1
(
1
L(D|Aj(k),Mk)
)}−1
which is called the harmonic estimator (Rafetery, et al. 1997) [54]. Or we can use
the Laplace-Metropolis approximation
log ̂L(D|Mk) = 1
2
P log(2pi)+
1
2
log |S|+
P∑
p=1
logsp+
N∑
i=1
logf(yi|A¯(k),Mk)+logf(A¯(k)|Mk)
in which |S| is the determinant of variance-covariance matrix for all parameters, sp is
the standard deviation of parameter p and A¯(k) is mean of the posterior distribution
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sampled by MCMC.
Step 3 Repeat Step 1 and Step 2 for Module 1 to K. Calculate the posterior
distribution of Pr(Mk|D) for each Module. By Occam’s Window criterion, we can
exclude some Modules which do not fulfill
P (Mk|D)
maxk∈1,...,KP (Mk|D) > η
by which η is the criterion set up based on the operating characteristics. Then the
adjusted Pr(Mk|D) of Pr(Mk|D) will be used in the following calculations.
Step 4 By the samples generated and the formula in Section 1.4 with Pr(Mk|D),
we compute the estimates of interested parameters.
To escape the identifiability problem due to over-parameterization, we fix the
priors for the variances of main effect parameters under both null and alternative
hypothesis. When we set up the distribution for variance of βs and γe , we want
the e±1.96σs = e±0.05 and e±1.96σe = e±0.05, corresponding to the 95% C.I. of param-
eters at (0.951, 1.051) for odds ratio. Under the alternative hypothesis, we set up
the distribution of βs and γe as e
±1.645σs = e±log3 and e±1.645γe = e±log4 for 90% C.I.,
corresponding to odds ratio intervals (1
3
, 3) for gene effects and (1
4
, 4) for environmen-
tal effects. So σ2s = σ
2
e = 0.00065, and σ
2
s = .446 and σ
2
e = .710. As shown in
the simulation studies, the prior settings for the variance do not affect the inferences
dramatically. We will omit those parameters by fixing the variances in the mixture
for the computation reasons. Similarly as main effects, we set σ2se = 0.00065 and
σ2se = .710.
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Data Generation
Suppose we want to generate a big data set with totally 1000 cases and 1000
controls. Firstly, we consider a fixed number of SNPs and exposure factors, say 6
SNPs with 2 non-null as bolded (SNP1, SNP2, SNP3, SNP4, SNP5, SNP6) and
2 exposure factors (exp1, exp2) with 1 non-null. And 5 interactions are non-null
among 12 (int11, int12, int21, int22, int31, int32, int41, int42, int51, int52, int61,
int62). The Minor Allele Frequency is 0.3 for null allele and 0.1 for non-null allele,
and the exposure prevalence is 0.1 for both the null and non-null factors. Therefore,
int41 reflects ’null null’ pair interaction, int22 int32 ’null non-null’, int61 ’non-null
null’ and int52 ’non-null non-null’ interactions.
We assume the prevalence of disease for all factors other than those within the
model is 0.2, which corresponds to intercept α = −1.386 by α = log( p
1−p). The odds
ratio for SNP minor allele is supposed to be 1 for null allele and 1.25 for non-null,
which corresponds to 0 and 0.223 by β = log(OR). Remark that we only use the
complete recessive genotype model with no dominant effects, in that the odds radio
between AA and aa for disease will be e2β. The odds radio for the exposure factors
are 1 for null and 2 for non-null, which corresponds to 0 and 0.693 of the coefficient.
One important assumption of the simulation is that the interaction terms are
generated independently away from each factor. The odds radio for the interactions
is 1 for null and 2 for non-null, which corresponds to 0 and 0.693 for the regression
coefficients of interactions.
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SNP Exposure Pr(M |Data)
s1 s2 s3 s4 s5∗ s6∗ e1 e2∗
Module1 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.197
Module2 0.2 0.2 0.2 0.2 0.8 0.8 0.2 0.8 0.788
Module3 0.8 0.8 0.8 0.8 0.2 0.2 0.8 0.2 4.6× 10−8
Module4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.011
Module5 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.003
Table 2.5: Posterior probability of each proposed prior in the elicitation
Model Evaluation
Table 2.5 shows that the proposed BMA model correctly identified the best prior
module thru the Bayesian Model Averaging process. Then we can use the BMA
way or the best module way or Occam’s Window [52] way to get the estimates and
compare the power of detecting true positive and negative effects among them as well
as with other methods like the single and full logistic regression models.
Discussion
Here we proposed an approach with several candidate priors for the mixture in-
dicators. By the Bayesian models averaging, the best fit prior Modules will play
important roles and worse fit Modules be removed automatically from the model
thru the posterior interpretations of models, in other words it is like the Bayes Fac-
tor way of model selection. The information about some SNPs or Exposure factors
being significant or trivial may exist from the previous studies or biological pathway
information. Then we can readily set some indictor priors to reflect this background
information thru the Modules. Also, the competing priors structure for the variances
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of the effects enable us to assign certain priors to reflect the proposals based on pre-
existing knowledge about the effects and researcher’s preference. Wakefield (2010) [46]
gives an idea of hierarchical models but fix all parameters about indicators. By this
modeling approach, we hope to gain more knowledge and model selection mechanisms
can greatly help increase the power and control the Type-I error.
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3. Bayesian Natural and Orthogonal Interaction Model for
Gene-Gene and Gene-Environment Interactions
3.1 Motivation
In the past few years, genome-wide association studies (GWAS) have substantially
contributed to the success of searching for causal genetic variants for complex dis-
eases and traits. In GWAS, hundreds of thousands of single nucleotide polymorphism
(SNP) are assayed from the participants in a relatively large study group. Usually
each genetic factor (locus) is analyzed separately. It has been proved a powerful tool
for investigating the underlying genetic reasons for the complex diseases and traits
[3] [56]. GWAS have found a large number of causal regions for the complex diseases,
which provided deep insight about the genetic mechanisms of diseases. However, a
large portion of the heritability in those diseases is still missing by GWAS studies.
One limitation of GWAS is that the interactions are ignored in those studies. So in
recent years more efforts are being made to investigate the interactions among the
genetic factors and between genetic and environmental factors that can explain the
missing heritability.
In this project, we first reviewed the Natural Orthogonal Interaction (NOIA)
Model that was proposed for studying the gene-gene and gene-environment interac-
tions. Then a Bayesian mixture model was proposed to be combined with the NOIA
model and the usual functional model. The proposed approaches were applied in the
lung cancer case-control studies.
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3.2 Natural and Orthogonal Interaction (NOIA) Model
3.2.1 Functional Model for Genotype-Phenotype Mapping
We first introduced the usual functional model for the genotype-phenotype map-
ping. Suppose that we have a study sample with n individuals. In the usual genotype-
phenotype quantitative trait locus (QTL) studies, the trait is usually assumed nor-
mally distributed. For the single locus study, the trait is influenced by a diallelic locus
with major allele A and minor allele a. For the ith individual, let yi be denoted as
the observed quantitative trait and Gi as the genotypic value for the diallelic locus.
There is a linear relationship between the quantitative trait and the genotypic value
as
yi = Gi + i (3.1)
where Gi can take three values G
11, G12 and G22 which are the genotypic values for
genotypes AA, Aa and aa. So for the n individuals in the sample, the vector of
genotypic values can be modeled with the individual design matrix Z
G1
G2
...
...
Gn

=

1 0 0
... ... ...
0 1 0
... ... ...
0 0 1

×

G11
G12
G22
 (3.2)
The genotypic values G11, G12 and G22 can be modeled as product of the genetic
design matrix D and the genetic effect values E
G = D × E (3.3)
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So let X denote the design matrix for the whole sample of study X = Z ×D. Then
we can model the relation between the quantitative trait and genotypic value for all
the individuals by Y = X ∗ E + . We then have
Y = Z ×D × E +  = Z ×G+  (3.4)
The question is about how to code the design matrix of the genotypic values D.
Different mapping methods make different assumptions. One of the widely applied
ways, which is referred as the usual functional model is coded as
G11
G12
G22
 =

1 0 0
1 1 1
1 2 0
×

R
a
d
 (3.5)
where R denotes the intercept, a denotes the additive displacement due to each incre-
ment in the number of variant alleles, and d denotes the deviation of the heterozygous
value from the additive model. When we inverted the design matrix D, we can get
the genetic effect value from the genotypic values
R
a
d
 =

1 0 0
−1/2 0 1/2
−1/2 1 −1/2


G11
G12
G22
 (3.6)
Here, R is also called the reference point which corresponds to the genotypic value G11
of the homozygotes AA. The additive effect a is half of the difference of the genotypic
values G11 and G22 for the homozygotes AA and aa. The dominance effect d is the
difference between the genotypic value G12 for heterozygote Aa and the average of
the genotypic values of G11 and G22. This is the model set up for quantitative trait
study. For case-control studies, we can propose the same design matrix with different
generalized linear models. As mentioned in Zeng (2002, 2005) [7] [57], there are
other coding approaches for functional models and the main difference depends on
the modeling for the reference point. For example, we may want to use the average of
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the two homozygotes AA and aa as the reference point, then the design matrix will
be 
G11
G12
G22
 =

1 1 0
1 0 1
1 −1 0
×

R
a
d
 (3.7)
Here we will only consider the first model (3.6). These models are called functional
models because they model the genetic effects as allele substitutions on genotypes
which provide the biological functions.
3.2.2 NOIA Model for Genotype-Phenotype Mapping
Another coding scheme was proposed by Alvarez-Castro and Carlborg (2007) [58]
for estimating the genetic effects for a quantitative traits and gene-gene interactions.
As shown in Ma et al (2012) [60], the design matrix G could be modeled as
G11
G12
G22
 =

1 −N¯ −2p12p22/V
1 1− N¯ 4p11p22/V
1 2− N¯ −2p11p12/V
×

µ
α
δ
 (3.8)
where p11, p12 and p22 denote the frequencies for the genotype of AA, Aa and AA.
And N¯ = p12 + 2p22 and V = p12 + 4p22− (p12 + 2p22)2 = p11 +p22− (p11−p22)2. N is
regarded as the frequency of the minor allele a in the population, N¯ is the estimate
of N in the sample and V is the variance of N¯ . Similarly, we can invert the design
matrix to get the estimate of the genetic effects from the genotypic values
µ
α
δ
 =

p11 p12 P22
p
′
11 p
′
12 p
′
22
−1/2 1 −1/2
×

G11
G12
G22
 (3.9)
where
p
′
ij = pij
Nij − N¯
V
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Here the design matrix in (3.8) is dependent on the genotype frequency for the locus
in the sample. Then the proposed statistical model is an orthogonal model which
produce the uncorrelated estimates of the parameters and the variance component
decomposition is also orthogonal [58]. Also, in the statistical model, the reference
point is µ = p11G
11 + p12G
12 + p22G
22.
There are two advantages for this statistical models as pointed out by Alvarez
(2007, 2008) [58] [59]. First, the estimate of each genetic effect is not influenced by
the estimate of other effects. So when we do variable selections, the results will be
consistent no matter of the number of loci and genotype frequencies. Second, the
variance components can be explained by being separated into different components
according to different effects. As shown in Alvarez (2007) [58], the design matrix of
the statistical model fulfill the orthogonality conditions specified by Zeng (2005) [57]:
XTX = DT × ZT × Z ×D = nDT ×Q×D (3.10)
where
Q =

p11 0 0
0 p12 0
0 1 p22
 (3.11)
Therefore, to attain the orthogonality feature, the design matrix D should fulfill the
conditions:
d11p11 + d22p12 + d12p22 = 0
d13p11 + d23p12 + d33p22 = 0
d12d13p11 + d22d23p12 + d32d33p22 = 0
The NOIA statistical model fulfills the above conditions as shown in Alvarez (2007)
[58] and the functional model does not hold this feature. This feature for the statistical
model is held even if the Hardy-Weinberg Equilibrium (HWE) is violated, because the
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coding scheme is based on the genotype frequencies not allele frequencies. This model
is appealing because it provides a consistent approach for the hypothesis testing as
well as the variable/model selection in the genetic studies, which is important for the
studies with multiple genetic and environmental factors with their interactions.
3.3 NOIA Model for Gene-Gene and Gene-Environment Interactions
We have already introduced the NOIA statistical model for the single locus study.
As mentioned earlier, under the NOIA model the estimate of the effect parameters
are uncorrelated. So when considering multiple loci for the quantitative trait, under
the condition of orthogonality, the estimates for one locus will not be affected by
the others. Here we first introduced the NOIA statistical model for two loci and the
model can be readily extended to more loci. Then we will also introduced the NOIA
statistical model for the gene-environment interaction as in Ma et al (2012) [60].
Suppose that we consider two diallelic loci Aij = AA,Aa, aa and Bij = BB,Bb, bb.
pij and qij are the genotype frequencies for Aij and Bij. Let NA denote the allele
frequency for allele a in the population and NB for allele b. We let N¯A and N¯B denote
the estimate of the allele frequency in the sample and VA and VB are denoted as the
variance of N¯A and N¯B, respectively. Therefore, we can get
N¯A = p12 + 2p22
VA = p12 + 4p22 − (p12 + 2p22)2
N¯B = q12 + 2q22
VB = q12 + 4q22 − (q12 + 2q22)2 (3.12)
By Alvarez-Castro and Carborg (2007) [58], the genotypic value GAB for the two loci
gene-gene interaction model are
GAB = DAB × EAB = (DB ⊗DA)× EAB
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where DB and DA are the NOIA statistical model design matrix for loci A and B.
The genotypic value GAB, the design matrix DAB and the genetic effect vector EAB
GAB = GB ⊗GA =

G11B
G12B
G22B
⊗

G11A
G12A
G22A
 =

G1111
G1211
G2211
G1112
G1212
G2212
G1122
G1222
G2222

(3.13)
DAB = DB ⊗DA =

1 −N¯B −2p12p22/VB
1 1− N¯B 4p11p22/VB
1 2− N¯B −2p11p12/VB
⊗

1 −N¯A −2p12p22/VA
1 1− N¯A 4p11p22/VA
1 2− N¯A −2p11p12/VA

(3.14)
and
EAB = EB ⊗ EA =

µ
αA
δA
αB
αα
δα
δB
αδ
δδ

(3.15)
79
Therefore we can get the statistical model for the two-loci study as
G1111
G1211
G2211
G1112
G1212
G2212
G1122
G1222
G2222

=

1 −N¯B −2q12q22/VB
1 1− N¯B 4q11q22/VB
1 2− N¯B −2q11q12/VB
⊗

1 −N¯A −2p12p22/VA
1 1− N¯A 4p11p22/VA
1 2− N¯A −2p11p12/VA
×

µ
αA
δA
αB
αα
δα
δB
αδ
δδ

(3.16)
So for the two loci studies, there are 9 parameters including one baseline(intercept)
µ, 4 main effects αA, δA, αB and δB and 4 pairwise interactions αα, αδ, δα and δδ.
Similarly, for the functional 2 loci model, the design matrix the Kronecker product
of the design matrix for each locus. And we can get
G1111
G1211
G2211
G1112
G1212
G2212
G1122
G1222
G2222

=

1 0 0 0 0 0 0 0 0
1 1 1 0 0 0 0 0 0
1 2 0 0 0 0 0 0 0
1 0 0 1 0 0 1 0 0
1 1 1 1 1 1 1 1 1
1 2 0 1 2 0 1 2 0
1 0 0 2 0 0 0 0 0
1 1 1 2 2 2 0 0 0
1 2 0 2 4 0 0 0 0

×

R
aA
dA
aB
aa
da
dB
ad
dd

(3.17)
For the usual functional model, there are one intercept R, 4 main effects aA, dA, aB
and dB and 4 pairwise interactions aa, ad, da and dd. In the functional model, the
80
design matrix is not based on the frequency of the genotype so the effect parame-
ters have different meanings from the statistical model (3.16). Actually the effect
parameter values of both models can be converted to each other by
EstatAB = (D
stat
AB )
−1DfuncAB E
func
AB
So far we have introduced the NOIA statistical model for the gene-gene interaction
models, but the NOIA model was also developed by Ma et al (2012) [60] for the gene-
environment interactions. Suppose we consider a binary environmental factor with a
genetic factor in the quantitative trait analysis. Let M denote the phenotypic values
for the environmental factor. In the usual functional model, we assume that
M =
 M1
M2
 =
 1 0
1 1
×
 Rm
am
 (3.18)
where M1 and M2 are the two levels of the phenotypic values of the environmental
factors, Rm is the baseline and am is the additive effect.Then we can get the effect
parameters as
Efuncm =
 R
am
 =
 1 0
−1 1
×
 M1
M2

Suppose that m1 = m and m2 = 1 − m are the frequency of the environmental
factors in the population. By using the same technique as in the NOIA model for
GxG studies, Ma el al (2012) [60] derived the orthogonal interaction model for the
environmental factor as
M =
 M1
M2
 =
 1 m− 1
1 m
×
 µ
αm
 (3.19)
and the effects can be estimated by
Estatm =
 µ
αm
 =
 m 1−m
−1 1
×
 M1
M2

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Therefore, by applying the Kronecker derivations, we get the following usual func-
tional model for the gene-environment interaction for one locus and one exposure as
GGM =

1 −N¯ −2p12p22/V m− 1 −(m− 1)N¯ −2p12p22/V
aG 1− N¯ 4p11p22/V m− 1 (m− 1)(1− N¯) 4p11p22/V
dG 2− N¯ −2p11p12/V m− 1 (m− 1)(2− N¯) −2p11p12/V
aM −N¯ −2p12p22/V m −m −2p12p22/V
aa 1− N¯ 4p11p22/V m m(1− N¯) 4p11p22/V
da 2− N¯ −2p11p12/V m m(2− N¯) −2p11p12/V

×

µ
αG
δG
αM
αα
δα

(3.20)
and the usual functional model as
GGM =

G11M1
G12M1
G22M1
G11M2
G12M2
G22M2

=

1 0 0 0 0 0
1 1 1 0 0 0
1 2 0 0 0 0
1 0 0 1 0 0
1 1 1 1 1 1
1 2 0 1 2 0

×

R
aG
dG
aM
aa
da

(3.21)
The parameters of effects in (3.20) and (3.21) can be converted to each other as
µ
αG
δG
αM
αα
δα

=

1 N¯ p12 1−m (1−m)N¯ (1−m)p12
0 1 p
′
12 0 1−m (1−m)p′12
0 0 1 0 0 1−m
0 0 0 1 N¯ p12
0 0 0 0 1 p
′
12
0 0 0 0 0 1

×

R
aG
dG
aM
aa
da

(3.22)
where p
′
12 = p12
N12−N¯
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3.4 Bayesian NOIA Model for Interactions
In the previous sections, we reviewed the NOIA statistical model for the gene-
gene and gene-environment interaction models. In reality, we may consider multiple
genetic and environmental factor simultaneously in the same model. Here we propose
a Bayesian model that combines the Bayesian mixture model and the NOIA statis-
tical model and we contrast model fitting with the Bayesian approach for the usual
functional model.
We consider gene-environment interaction model (3.16) and the other models for
the gene-gene interaction model can be similarly set up. In quantitative trait studies,
we assume that the trait will follow a normal distribution with the mean as the
genotypic value
yi = Gi + i
where Gi is the genotypic value for the genotypes of ith observation.
yi = Zi ×D × E (3.23)
where Zi is the design matrix for the genotype of ith observation and D is the design
matrix as in 3.16 and E is the effect parameters. Therefore, the parameter µ is the
intercept in the linear regression, and αA, δA, αB, δB are the parameters for the
main effects and αα, δα, αδ and δδ are the parameters for the pairwise interactions.
Therefore, we propose the Bayesian mixture model for each of the parameters as
αA ∼ N(0, I1ασ21α + (1− I1α)σ21α)
δA ∼ N(0, I1δδ21δ + (1− I1δ)σ21δ)
αB ∼ N(0, I2ασ22α + (1− I2α)σ22α)
δB ∼ N(0, I2δδ22δ + (1− I2δ)σ22δ)
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for the interaction parameters
αα ∼ N(0, Iαασ2αα + (1− Iαα)σ2αα)
αδ ∼ N(0, Iαδσ2αδ + (1− Iαδ)σ2αδ)
δα ∼ N(0, Iδασ2δα + (1− Iδα)σ2δα)
δδ ∼ N(0, Iδδσ2δδ + (1− Iδδ)σ2δδ)
for the intercept µ ∼ N(0, σ2µ)
In the second level we assume the hyper-priors for each of the indicators,
for SNP A:
I1α ∼ bernoulli(p1α)
I1δ ∼ bernoulli(p1δ)
for SNP B:
I2α ∼ bernoulli(p2α)
I2δ ∼ bernoulli(p2δ)
for the interactions:
Iαα ∼ bernoulli(pαα)
Iαδ ∼ bernoulli(pαδ)
Iδα ∼ bernoulli(pδα)
Iδδ ∼ bernoulli(pδδ)
Therefore, we can conduct the Bayesian inference for the parameters and select the
significant genetic effects from the model with multiple genetic factors. In the original
NOIA statistical model, all the results are based on the parameter estimation. Ma
et al (2012) [60] compared the hypothesis test for the gene-environment interactions.
By our proposed model, we can also do the variable selection by the mixture model.
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This framework can be extended to the gene-environment interaction, usual functional
models. For the case-control binary outcome, we may propose a similar framework
for a generalized linear model. Suppose that Y is the vector indicating the disease
status of all observations
Yi ∼ bernoulli(pi)
logit(pi) = Gi = Zi ×D × E
Therefore, the similar prior structures can be proposed for logistic regression models.
3.5 Real Data Example
We conduct the real data analysis using the Bayesian NOIA model and the
Bayesian Functional model on the lung cancer dataset Totally we consider 6 SNPs
and 1 environmental factor. For each SNP, we model both the additive effect and
dominance effect. For the smoking, there is only one additive effect. For interactions,
there are 12 pairwise gene-environment interactions. To illustrate the methods, we
do not take into account the gene-gene interactions in the model. The results are
shown in Figure 3.1. Both models identifies the smoking effects. The NOIA statisti-
cal model find the interaction between the additive effect and the smoking, while the
usual functional model does not identify it.
3.6 Discussion
In this chapter, we introduced the NOIA statistical model and the usual functional
model for the Genotype-Phenotype mapping. Then the NOIA statistical model for
the gene-gene interactions and gene-environment interactions was introduced. In
practice, we may be interested in making the variable selection on the SNP level.
Then a group selection approach could be attempted for achieving this goal. To find
out the predisposing SNPs from a candidate sets, we may put extra constraint on
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the priors of parameters. One approach to prior structure set up for the gene-gene
interactions can be
for SNP A:
I1α = I1δ ∼ bernoulli(p1)
for SNP B:
I2α = I2δ ∼ bernoulli(p2)
and for interactions:
Iαα = Iαδ = Iδα = Iδδ ∼ bernoulli(p3)
By this modeling scheme, each SNP and the interaction can be selected as a group
comprising several genetic effects.
Another extension could be using the Lasso-type hyper-priors for the variance
components, so the parameter will shrink to zero as well as being selected in the
model. For example, we assume that
for SNP A:
αA ∼ I1α × dexp(λ1) + (1− I1α)× 1∅
δA ∼ I1δ × dexp(λ1) + (1− I1δ)× 1∅
for SNP B:
αB ∼ I2α × dexp(λ2) + (1− I2α)× 1∅
δB ∼ I2δ × dexp(λ2) + (1− I2δ)× 1∅
for the interactions:
αα ∼ Iαα × dexp(λ3) + (1− Iαα)× 1∅
αδ ∼ Iαδ × dexp(λ3) + (1− Iαδ)× 1∅
δα ∼ Iδα × dexp(λ3) + (1− Iδα)× 1∅
δδ ∼ Iδδ × dexp(λ3) + (1− Iδδ)× 1∅
86
Here σ21, σ
2
2 and σ
2
3 are the common tuning parameters for SNP A, SNP B and the
interactions.
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Figure 3.1.: Bayesian NOIA coding analysis results for the lung cancer study.
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4. Bayesian Empirical Shrinkage-Type Estimator and
Bayesian Model Averaging Approaches for
Gene-Environment Interactions and Extensions to Adaptive
Borrowing Historical Data in Clinical Studies
4.1 Motivation
In the previous sections, we introduced the proposed Bayesian statistical models
for gene-gene and gene-environment interactions based on the framework of variable
selection in generalized linear models. Alternative Bayesian statistical models exist
for exploring the gene-environment interactions under the other statistical frame-
work. In this section, we will first review two Bayesian approaches that were recently
developed to adaptively model the gene-environment interactions depending on the
independence between the genetic and environmental factors. Then, we extend the
idea to the problem of adaptive borrowing the data from historical studies. We will
focus on the evaluations of the event rate, such as in clinical or epidemiological stud-
ies. Simulation studies are conducted to demonstrate the advantages of the novel
approaches.
4.2 Bayesian Hierarchical Meta-Analysis Model
Suppose that we are interested in borrowing the information from the previous
studies such that the sample size can be enriched. Let p1 and p0 denote the current
and historical event rates. y1 and n1 are denoted as the total number of events and
total sample size in current study. y0i and n0i with i = 1, 2, ..., n are denoted as the
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total number of events and total sample size in each of the previous ith study. For
illustration purpose, we first consider the simple case with one current study and one
historical study. The maximum likelihood estimator for the event rate of the histor-
ical study is y0
n0
and for the current study is y1
n1
. When we assume the existence of
exchangeability between the two studies, they can be pooled together to provide the
estimator of the event rate as y1+y0
n1+n0
.
Here we use a Bayesian hierarchical model to model the relationship between the
two studies. For the current study, we assume
y1 ∼ binomial(n1, p1)
logit(p1) = α1
α1 ∼ N(µa, 1/τa)
µa ∼ N(a, b)
τa ∼ Gamma(c, d) (4.1)
For the historical study, we assume
y0 ∼ binomial(n0, p0)
logit(p0) = α0
α0 ∼ N(µa, 1/τa) (4.2)
Now we want to compare this with the frequentist approach. Since the endpoint
of the study is event rate, we used the Binomial exact test to compare with the
Bayesian model’s performance. For the Binomial exact test, the p-value is equal to
the probability of obtaining the event number as equal or less than the observed one.
We performed the exact test for both of the current study and the pooled study which
blindly combined the two data sets together. For the Bayesian approach, we imple-
mented two different priors for the variance components of the model to compare it
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with the exact test. c = 10, d = 10 is the prior that is relatively informative due to
its smaller variance of 0.1. c = 0.001, d = 0.001 is a more diffuse prior with a larger
variance of 1000. This reflects our belief that we expect to see similarities between
the two studies due to the exchangeability.
4.2.1 Example
Suppose that in one historical study we collect 314 observations. In the current
study, we want to evaluate the study power and Type-I error given the sample size
100. We want to test the hypothesis about the rate:
H0 : p0 ≥ 0.08
Ha : p1 < 0.08 (4.3)
To calculate the Type-I error rate, the simulation steps are:
1. Fix n1 = 100, n0 = 314, p1 = 0.08 and p0 = 0.04
2. Randomly generate simN numbers of event numbers yj1 and y
j
0, j = 1, 2, ..., simN
by
y1 ∼ binomial(p1, n1)
y0 ∼ binomial(p0, n0)
3. Under each yj1, y
j
0 with the fixed number n1 and n0, we implemented 4 ap-
proaches mentioned above and use α = 0.05 as the significance level for exact
test. For the Bayesian approach, we calculate pi = Pr(p1 < 0.08). When
pi > 0.95 we reject H0, otherwise we accept it.
4. Then we count how many rejections happened for each of the approaches.
no of rejection
simN
is the estimated Type-I error rate.
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enumerate To calculate the Power for Scenario 2, the simulation steps are:
1. Fix n1 = 100, n0 = 314, p1 = 0.04 and p0 = 0.04
2. Randomly generate simN numbers of event numbers yj1 and y
j
0, j = 1, 2, ..., simN
by
y1 ∼ binomial(p1, n1)
y0 ∼ binomial(p0, n0)
3. Under each yj1, y
j
0 with the fixed number n1 and n0, we perform the 4 approaches
mentioned above and use α = 0.05 as the significance level for exact test. For
the Bayesian approach, we calculate pi = Pr(p1 < 0.08). When pi > 0.95 we
reject H0, otherwise we accept it.
4. Then we count how many rejections happened for each of the approaches.
no of rejection
simN
is the estimated power.
4.2.2 Result
Scenario 1 Scenario 2 Scenario 3 Scenario 4 Scenario 5
p1, p0 0.04, 0.04 0.04, 0.03 0.04, 0.03 0.03, 0.03 0.03, 0.04
sample size n1 100 100 50 100 100
Type-I Power Type-I Power Type-I Power Type-I Power Type-I Power
No borrowing 0.03 0.36 0.03 0.36 0.02 0.12 0.03 0.58 0.03 0.58
Full borrowing 0.73 0.91 0.89 1.00 0.93 1.00 0.89 1.00 0.73 0.95
Gamma(0.001, 0.001) 0.34 0.83 0.37 0.90 0.53 0.89 0.37 0.98 0.34 0.93
Gamma(10, 10) 0.10 0.58 0.10 0.60 0.09 0.42 0.10 0.74 0.10 0.74
Table 4.1: Frequentist operating characteristics for the 5 scenarios
We performed 100 times of replicates for comparing the performances of the four
approaches in Table 4.1. In Scenario 1, the ’no borrowing’ exact test controls the
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Type-I error well with a lower power. On the contrary, the ’full borrowing’ exact test
has a large power while the type-I error is poorly inflated. The Bayesian hierarchical
model with prior Gamma(0.001, 0.001) has a larger power than the single study while
the type-I error is not that inflated. The Bayesian model with Gamma(10, 10) has a
better power than the ’no borrowing’ approach while the type-I error is still controlled
under 0.1. In Scenario 2, the historical rate is a little smaller as 0.03. When compared
with Scenario 1, the ’No borrowing’ approach has no improvement. The type-I error
of ’Full borrowing’ is more inflated than in Scenario 1. Both of the Bayesian model
has some improvement on power. The ’Gamma(10,10)’ also control the false positive
rate as in Scenario 1. When we decrease the sample size of the current study from
100 to 50, we observed that all methods perform worse than in Scenario 2. Still,
the Bayesian approach performed better than the frequentist exact test. In Scenario
4 and Scenario 5, the current rate was changed from 0.04 to 0.03 in the simulation
setup. We find that the Bayesian approaches have a better power than the single
study without borrowing any information. They also control the Type-I error rate
better than the fully borrowing study. Especially ’Gamma(10,10)’ can control the
Type-I error under the level of 0.1 and have comparably larger power as the full
borrowing approach.
4.2.3 Comment
In this study, the rate estimate without borrowing any information is the unbiased
estimate. If we pool the historical study with the current study, the rate estimate
will be the biased estimate. However, the power of the study can be improved if the
historical study is confirmed to be similar as the current study. In this study, the
Bayesian hierarchical model helped to borrow information from the previous trial to
improve the study. The power was put higher than the single study and the type-I
error rate is controlled relatively well. Here for the Bayesian hierarchical model, we
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use two priors which reflect two kinds of belief about the connection between the
current study and historical study. Overall, the Bayesian approach performed more
adaptively to the information we have. This means that our study can borrow partial
information from the historical study thus help improve our current trial study.
4.3 Bayesian Empirical Shrinkage-Type Estimator
4.3.1 Motivating Background
Population based case control studies are commonly used to investigate the ef-
fects of gene-environment interactions on complex diseases. It is well known that
case-control studies have poor power for detecting the multiplicative interactions [5].
On the other hand, under the assumption of independence for the underlying popu-
lation, we can conduct the test with more power for the multiplicative interactions
based on the odds ratio of dichotomous genotypes and environmental factors in the
case group of observations. However, when the independence assumption is violated,
the method can result in inflated Type-I error. To solve this uncertainty on the
bias-efficiency trade-off, people have proposed approaches such as two-step testing
procedure [61] that test the assumption of the independence assumption first and
then decide whether to use the case-only approach for reaching larger power or case-
control complete approach for controlling lower bias. However, this two-step testing
procedure requires relatively large sample size to reach the power for testing the in-
dependence. Also, the two-step procedure is a discrete process in which the variance
of the test statistics is complicated to measure. Mukherjee [62] [63] proposed an
empirical Bayesian shrinkage estimator to solve the bias and efficiency dilemma by
taking a composite estimator by a weighted average of the case-only and case-control
estimators. The weights are dependent on the dependence between the genotypes
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and environmental factors but irrespective of the test of independence.
Suppose that we are considering the case-control study with one dichotomous
genetic factor and one dichotomous environmental factor. SNP=1 denotes the sus-
ceptible genotype carrier and EXP=1 denotes exposed to the environmental factor.
So we will have eight numbers according to each category as in table 4.3. Then
x1 = (x100, x101, x110, x111) is the vector of the observed frequency according to each
genotype and exposure combination in the cases. And x0 = (x000, x001, x010, x011)
denotes the data vector for the controls. Let the corresponding probability for each
category will be p1 = (p100, p101, p110, p111) and p0 = (p000, p001, p010, p111) Therefore,
the observed number for each category can be viewed as two multinomial distribution
as
x1jk ∼Multinomial(n1, p1jk)
x0jk ∼Multinomial(n0, p0jk) (4.4)
where
∑
j,k
p1jk = 1∑
j,k
p0jk = 1 (4.5)
As illustrated in Muckerjee (2008) [62], Let OR10 =
p000p110
p010p100
denotes the odds ratio
associated with the genotype for the non-exposed observations. Similarly, we let
OR01 =
p000p101
p001p100
denotes the odds ratio for exposed observations. Also, we let OR11 =
p000p111
p011p100
denotes the odds ratio for the observation with the exposure and susceptible
genotype to the observation without either risk factor. Therefore, the multiplicative
interaction parameter as in Chatterjee (2008) [62] is
φ =
OR11
OR10OR01
=
p001p010p100p111
p000
(4.6)
95
SNP=0 SNP=1
EXP=0 EXP=1 EXP=0 EXP=1 Total
Case x100 x101 x110 x111 n1
Control x000 x001 x010 x011 n0
Table 4.2: Data structure for the case-control study with a dichotomous genotype
(SNP) and a dichotomous environmental factor (EXP).
Let β denotes the multiplicative interaction parameter as β = log(φ). Then the
unbiased estimator of this parameter in the case-control studies will be
βˆCC = log(
x001x010x100x111
x000x011x101x110
) (4.7)
Also, for the multiplicative interaction parameter β, there exists
βCC = log(
p001p010p100p111
p000p011p101p110
) = log(
p100p111
p101p110
/
p000p011
p001p010
) (4.8)
Therefore, if in the control group the genotype and exposure do not interact,
βCO = log(
p100p111
p101p110
) (4.9)
So in the case, the estimator for β under the conditional of being independent in the
control group will be βˆco:
βˆCO = log(
x100x111
x101x110
) (4.10)
Then the difference between βCC and βCO is the criteria to evaluate the independency
assumption in the general population
θGE = βCO − βCC
θˆGE = βˆCO − βˆCC
= log(
x000x011
x001x010
) (4.11)
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Then they proposed a new Bayesian empirical shrinkage-type estimator βˆEB which
is the weighted average of the estimator βˆCC under the case-control studies and the
biased estimator βˆCO [62]:
βˆEB =
σˆ2CC
θ2GE + σˆ
2
CC
βˆCC +
θˆ2GE
θ2GE + σˆ
2
CC
βˆCO (4.12)
where all the parameter estimates are based from table 4.3. θGE =
p000p011
p001p010
and σˆ2CC
is the standard error of the estimator of βCC . By taylor’s approximation, they gener-
ate the variance of the Bayesian empirical shrinkage-type estimator βˆEB. Intuitively,
as the data provide evidence about the independence between the genetic and envi-
ronmental factor in the controls θˆGE → 0, βˆEB → βˆCO. When the independence is
violated and as the sample size increase ˆσ2CC → 0, then βˆEB → βˆCC .
4.3.2 Methodology
In the previous study, suppose we only have two study. pˆ1 =
x1
n1
is the MLE of
the true rate p1. If we assume the exchangeability of the historical study and current
study we can derive an estimate of p1 as pˆpool =
x1+x0
n1+n0
. So we can regard ppool as the
restricted MLE.
Event Total Rate
Current x1 n1
x1
n1
Historical x0 n0
x0
n0
Pool x1 + x0 n1 + n0
x0+x1
n0+n1
Table 4.3: Data structure for borrowing data from single historical study
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We define the difference between pˆ1 and pˆpool as γˆ = pˆpool−pˆ1, which is an estimator
of true difference ppool− p1. We propose the following Bayes empirical shrinkage-type
estimator for p1 as:
pˆEB =
var(pˆ1)
var(pˆ1) + γˆ2
× pˆpool + γˆ
2
var(pˆ1) + γˆ2
× pˆ1
4.3.3 Asymptotic Property
This estimator is a kind of estimator that weighs adaptively on the MLE and
restricted MLE. The weigh depends on the estimation property of p1 and the difference
between the two estimators.
• As γˆ2 → 0, the event rate of the two studies getting closer, pˆEB → pˆpool
• As γˆ2 →∞, the event rate of the two studies getting larger, pˆEB → pˆ1
• As n1 → 0, then var(pˆ0)→∞, then pˆEB → pˆpool
• As n1 →∞, then var(pˆ0)→ 0, then pˆEB → pˆ1
We set up a simulation to study the property of the estimator. In Figure 4.1, we
plot the results for 4 different scenarios based on the different sample size. We fixed
the true value of p1 at 0.2. We use ∆ = ppool − p1 and change the value of ∆ to get
the true value of p0 as
(p1 + ∆)× (n1 + n0)− p1n1
n0
Therefore, we run an 1000 times simulation and under each simulated data, we cal-
culated mean absolute error (MAE) by 1
1000
∑ |pˆEB − 0.2| for the empirical Bayesian
estimator 1
1000
∑ |pˆ1 − 0.2| for the current study estimate and 11000∑ |pˆpool − 0.2| for
the pooled study.
In the first study with sample size n1 = 50 for current study and n0 = 50 for
historical study. We change the setup in the difference between the current study
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Figure 4.1.: Simulation results for comparing the borrowing performances
rate and pool study rate while controlling the event rate of current study at fixed
value 0.2. We want to examine the estimator shrinkage property when changing the
difference between these two estimators.
We can observe that as the difference ∆ is around 0, meaning that the two studies
are very alike, the empirical Bayesian estimator pˆEB shrink to the pool estimator pˆpool.
While the ∆ getter larger, the shrinkage estimator will be more close to the single
study estimator pˆ1. As we increase the sample size in the historical study to 100, pˆEB
shrink more to the pool estimator. When we increase the sample size of the current
study, all estimators get improved while the empirical estimator shrink more to the
current study when the difference get larger. And as we increase both sample sizes
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of the two studies, the empirical estimator perform adaptively better. It means that
the empirical Bayes estimator only shrink to the pool study estimator ppool when the
two study rates are very close. It is true for the practical meaning since we already
have large sample size in the current study.
4.3.4 Inference
As derived similarly as in Mukerjee (2008) [62] [63], we derive the approximation
of the estimate variance of pEB.
V ar(pˆEB) = V ar(pˆpool) + (
γˆ2(γˆ2 + 3V ar(pˆ1))
(V ar(pˆ1) + γˆ2)2
)2 × V ar(γˆ)
where,
V ar(pˆ1) =
pˆ1(1− pˆ1)
n1
V ar(pˆpool) =
pˆpool(1− pˆpool)
n1 + n0
V ar(γˆ) =
pˆpool(1− pˆpool)
n1 + n0
+ pˆ1(1− pˆ1)× ( 1
n1
− 2
n1 + n0
)
We can construct the 1-sided Wald confidence interval (−∞, pˆEB+Z(1−α)×se(pˆEB))
to test the null hypothesis p1 > 0.2.
4.4 Bayesian Model Averaging and Bayesian Model Selection
4.4.1 Motivating Background
In the previous section, we have derived the Bayesian empirical shrinkage-type
estimator for borrowing the historical data in device trials. The current study data
provides the unbiased estimate, while the combined study provides larger power de-
pending on the homogeneity. This is analogous to the bias-variance dilemma in
gene-environment interaction studies. The criteria for weighting the estimate in the
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gene-environment interaction is the independency assumption between genetic and
environmental factor. In the borrowing historical data study, the criteria is the ho-
mogeneity assumption. This borrowing process is a continuous process by which the
empirical estimate will change smoothly. The Bayesian model averaging is another
approach that has been developed for taking the uncertainty in the model compar-
ison/selection for the estimation. There is a posterior probability assigned to each
model, which will play parts in the final model averaging process.
The Bayesian Model Averaging approach was initially proposed by Raftery (1997)
[52] for the linear regression model, in which the uncertainty when selecting the model
among all possible is considered. The BMA approach was also applied in the case-
control studies by Raftery (2001) [64] to investigate the generalized linear model
with interactions. Li and Conti (2009) [65] extend the BMA approach to the gene-
environment interactions studies by balancing the power and bias among the case-only
and case-control studies. They proposed the Bayesian model averaging approach to
combine case-control and case-only studies.
Suppose that we have a case-control dataset with a disease status variable Z, a
binary genetic factor X and an environmental factor Y . The interaction between the
genetic factor and environmental factor could be tested using the logistic regression
model:
Z ∼ bernoulli(P )
logit(P ) = α + βX + γY + θXY (4.13)
Then by 4.13,
log(N ∗ Pr(Z = 1))− log(N ∗ Pr(Z = 0)) = α + βX + γY + θXY (4.14)
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where N is the total number. Therefore, the model can be viewed as a log-linear
model, in which the logarithm of the expected number of observations in each cell
can also be modeled in [66] as
log(µ|Z,X, Y ) = α0 + β0X + γ0Y + θ0XY + αZ + βZX + γZY + θZXY (4.15)
And 4.13 and 4.15 have the same parameters α, β, γ and θ.
From 4.15, we can have the following equations:
log(µ|Z = 0, X = 1, Y ) = α0 + γ0Y + θ0Y
log(µ|Z = 0, X = 0, Y ) = α0 + γ0Y (4.16)
So under the assumption of independence, in the control date log(µ|Z = 0, X =
1, Y ) = log(µ|Z = 0, X = 0, Y ), therefore θ0 = 0. Under this assumption,
log(µ|Z = 1, X = 1, Y ) = α0 + β0 + γ0Y + α + β + γY + θY
log(µ|Z = 1, X = 0, Y ) = α0 + γ0Y + α + β + γY (4.17)
And the interaction can be evaluated based on the model in the case-only study as
X ∼ bernoulli(pi)
logit(pi) = β0 + θY (4.18)
So here the case-control estimator of the interaction parameter is θCC is under the
model 4.13 and the case-only estimator of the interaction parameter is θCO under the
model 4.18. And all these estimations are under the framework of 4.15. (Li and Conti)
[65] then applied the Bayesian model averaging (BMA) approach to combine these
two parameters according to different models. Model averaging has been proposed to
account for uncertainty brought in by different models. Unlike the Model Selection,
the model averaging explicitly presents the uncertainty of models and make inferences
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based on all competing models rather the best model. Here, θ is the parameter of
interest for evaluating the gene-environment interactions. Let M1 denote the model
4.13 as M1 and 4.18 as M2 and the BMA estimator θBMA would be
θBMA = Pr(M1|data)× θCC + Pr(M2|data)× θCO
Pr(Mk|data) = Pr(data|Mk)Pr(Mk)∑
Pr(data|Mk)Pr(Mk)
Pr(data|Mk) =
∫
Pr(data|θk)× f(θk|Mk)dθk (4.19)
Also, the variance of the parameters could be measured and then the Wald test could
be applied for the hypothesis test.
4.4.2 Methodology
First of all, we will consider the case of only two studies and then generate the
approach to multiple studies. Our hypothesis is that
H0 : p1 = p0
Ha : p1 6= p0
So if we believe H0 is right, we will pool the two study together. Otherwise we will
only use the current study to estimate p1. We have to specify our prior belief about
H0 and Ha according to Pr(H0) + Pr(Ha) = 1. Then we can calculate the posterior
of each model as:
p(H0|data) = p(H0)× p(data|H0)
p(H0)× p(data|H0) + p(Ha)× p(data|Ha)
where we can assume Pr(H0) = Pr(Ha) =
1
2
that reflects an non-informative belief
about the parameters. Here, ’data’ refers to the patients data in both studies. After
some integration, we can get the closed form of the posterior of each model as
p(H0|data) = Beta10
Beta1 ×Beta0
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where,
Beta10 = Beta(x1 + x0 + 1, n1 + n0 − x1 − x0 + 1)
Beta1 = Beta(x1 + 1, n1 − x1 + 1)
Beta0 = Beta(x0 + 1, n0 − x0 + 1)
And
p(Ha|data) = 1− p(H0|data)
Therefore, we can get the posterior of the f(p1|data) as
f(p1|H0, data)× p(H0|data) + f(p1|Ha, data)× p(Ha|data)
where f(p1|H0, data) is the posterior of p1 under the model H0 : p0 = p1 and
f(p1|Ha, data) is the posterior of p1 under the model Ha : p0 6= p1. So the poste-
rior of p1|data is a weighted mixture of two parts. As illustrated in Hoeting (1999)
[53], if we want to get the point estimate of p1, the BMA estimate denoted as pˆ
BMA
1
should be
pˆBMA1 = E(p1|x1, x0)p(H0|data) + E(p1|x1)p(Ha|data)
In Figure 4.2, we plot the distribution of p1|data under different situations. If
we observed 3 events among 20 patients in the current study and 14 events among
30 patients in the historical study, the posterior distribution will be approximately
the same as the distribution of the single study. If we observed fewer events in the
historical data, the posterior is approaching the historical study and stay between
the single study and the pool study. Finally suppose we observe 5 events among 30
patients in the historical study, the posterior shrinks to the pooled distribution. So
the distribution of the proposed estimate of p1 has the property of adaptively deciding
the borrowing information based on the similarities between the current study and
historical study. Since we can draw the posterior samples for p1|data by Monte Carlo
approach, we can do hypothesis test based on the sampled posterior distribution. For
example, if Pr(p1 < 0.2|data) > Pcut we reject H0.
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Figure 4.2.: Posteiror distributions of the estimator according to degress of homo-
geneity
4.4.3 Simulation
Here we run 1000 simulations to compare the ’Empirical Bayes’, ’Bayesian Model
Averaging’ (BMA) and frequentist Binomial exact test with fully borrowing and no
borrowing approach for the event rate test. So we define
H0 : p1 ≥ 0.2
Ha : p1 < 0.2
We compare these approaches based on the Frequentist Operating Characteristics.
We change the true current event rate and historical event rate and calculate the
power or Type-I error based on the setup.
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Figure 4.3.: Frequentist operating characteristics for Scenario 1 with 20 observations
in the current study and 50 observations in the historical study
4.4.4 Results
In Figure 4.3, when the current study sample size is 20 and historical is 50, both
of the empirical Bayes approach and BMA outperform the full borrowing and no
borrowing approaches. The empirical Bayes approach has a larger power than the
BMA approach, but produce a higher level of Type-I error. When we increase the
sample size from 20,50 to 50,100 as in Figure 4.4, the performance of all models get
improved. The BMA shrink more obviously to the current study as the similarity
between the current and pool get weak. When we have a relative larger sample size
as in Figure 4.5, the graph shows that the two approaches proposed outperform the
no-borrowing approach. When the true rate of the current study is in the same area
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Figure 4.4.: Frequentist operating characteristics for Scenario 1 with 50 observations
in the current study and 100 observations in the historical study
of the alternative hypothesis, the methods effectively borrow information to increase
the power. In Figure 4.6, since the sample size is already large enough to detect
the difference, the two approaches proposed perform similar as the no borrowing
approach.
Overall, the empirical Bayesian approach and Bayesian model averaging approach
has the adaptive property that can borrow the information from the historical study
information to improve the frequentist operating characteristics.
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Figure 4.5.: Frequentist operating characteristics for Scenario 1 with 100 observations
in the current study and 300 observations in the historical study
4.4.5 Alternative Extensions
Multiple Study/Arm BMA
The BMA approach has the property to be extended to multiple studies. Now
suppose we have 3 studies with their event rate as p0, p1 and p2, in which p2 is the
current rate for the current study. Then we can make a group of hypothesis,
H1 : p0 = p1, p0 = p2, p1 = p2
H2 : p0 = p1, p0 6= p2, p1 6= p2
H3 : p0 6= p1, p0 = p2, p1 6= p2
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Figure 4.6.: Frequentist operating characteristics for Scenario 1 with 300 observations
in the current study and 300 observations in the historical study
H4 : p0 6= p1, p0 6= p2, p1 = p2
H5 : p0 6= p1, p0 6= p2, p1 6= p2
Therefore, we can simulate get the posterior p2|data, which is a finite mixture
with all Hi|data, i = 1, 2, 3, 4, 5. One unique feature of this approach is that it
can fully consider all the possibility of the rations between the different studies. As
illustrated in below, the ’commensurate’ will assume the homogeneity among the
historical groups. But in here, we do not need that assumption.
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Equivalence Margin
Also, based the on original hypothesis, we may set up the hypothesis as:
H0 : |p1 − p0| > δ
Ha : |p1 − p0| ≤ δ
So compared the original BMA model, this model’s focus on a region of hypothesis
rather than a diagonal line for the null hypothesis. This set-up provides us some
flexibility to measure the difference between the event rate. Also, it has clinical
meaning that the physicians can assign clinical meaningful margin into the study.
The calculation will be more complex. We have tried the simplest two studies cases,
it shows that the inference can be improved than the original BMA approach.
Bayesian Decision-Theoretic Optimal Boundary
In the last section, we introduced the concept of equivalence margin. For the
hypothesis in the Bayesian model Averaging
T0 : p1 − p0 = 0
Ta : p1 − p0 6= 0 (4.20)
We can borrow the equivalence trial test idea to evaluate the plausibility to ’pool’ the
data together or not by introducing
T0 : |p1 − p0| ≥ δ
Ta : |p1 − p0| < δ (4.21)
where δ is the equivalence margin, by which we want to pool the data together if Ta
is true and vice versa. This is similar as equivalence hypothesis test.
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As for the most simple case, p0 is assumed known without uncertainty(large his-
torical study) and the sample size of our current study is n1. We use composite single
point hypothesis as
T0 : p1 = p0
Ta1 : p1 = p0 − δ
Ta2 : p1 = p0 + δ (4.22)
Same as before we assume that the three hypothesis are equally likely apriori
p(T0) = p(Ta1) = p(Ta2) = 1/3 (4.23)
Here we propose to use the Bayesian decision-theoretic framework to find the ’optimal’
solution about deciding if we should pool the data(BMS). We want to find the lower
bound φL and upper bound φU of the event rate, such that when the observed event
number x1 fulfills n1φL < x1 < n1φU we pool the data otherwise we will not pool. We
define a loss function as the probability of making the wrong decision (pool or not)
L(φL, φU) = p(x1 ≥ n1φU
⋃
x1 ≤ n1φL|T0)× p(T0)
+p(n1φL < x1 < n1φU |Ta1)× p(Ta1)
+p(n1φL < x1 < n1φU |Ta2)× p(Ta2) (4.24)
So for each given p0, n1 and δ, we can solve φL and φU by minimizing L(φL, φU).
Then the optimal bound solution is:
φˆL = argmin
φL
p(T0)Fbin(xi ≤ n1φL;n1, p0)− p(Ta1)Fbin(xi ≤ n1φL;n1, p0 − δ)
−p(Ta2)Fbin(xi ≤ n1φL;n1, p0 + δ)
φˆU = argmin
φU
p(T0)(1− Fbin(xi < n1φU ;n1, p0)) + p(Ta1)Fbin(xi < n1φU ;n1, p0 − δ)
+p(Ta2)Fbin(xi < n1φU ;n1, p0 + δ) (4.25)
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Figure 4.7.: Decision boundary for different equivalence margins with 20 observations
in the current study
δ 0.05 0.10 0.15 0.20 0.25
No.of events 6 6 [5, 7] [4, 7] [3, 8]
Table 4.4: Decision boundary for different equivalence margins with 20 observations
in the current study
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Figure 4.8.: Decision boundary for different equivalence margins with different num-
bers of observations in the current study
113
Predictive Probability
All our previous Bayesian hypothesis testing is based on the calculation of the
posterior probability of certain claim. If the probability is larger than some cut-off
point, we will reject or accept the corresponding hypothesis. Next we will introduce
the general idea of predictive probability approach and use a simple example to illus-
trate the difference from posterior probability approach.
Suppose that for single arm trial, we have observed y1 events out of n1 patients.
In posterior probability we will reject H0 : p1 > 0.2 if
Pr(p1 < 0.2|y1) > 0.95
Now suppose we have total another n2 patients who will be treated by the current
arm. So similarly the posterior probability we will reject H0 based on all the data is
Pr(p1 < 0.2|y1, y2) > 0.95
However, we actually have not observed y2, we can regard the above as a random vari-
able taking value 0 or 1 depending on the value of y2 .Then we need to average out y2
from the above conditional probability with the predictive posterior probability,
which follows a beta-binomial models.
f(y2|y1) ∼ Beta−Binomial(n2, α + y1, β + n1 − y1)
Then we want to get our predictive probability as
n2∑
y2=1
I(Pr(p1 < 0.2|y1, y2) > 0.95)× f(y2|y1)
So we can regard the posterior probability model as the direct evidence to make
our conclusion. The predictive probability model is a finite mixture of each poste-
rior model under different potential future outcomes within the total sample size.
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There are comprehensive introductions about these ideas and practical examples for
working on. The idea of predictive probability model can fulfill the purpose of contin-
uous/group monitoring the study observations, since the results depend on the future
sample size.
4.5 Bayesian Commensurate Model
4.5.1 Introduction
In all the approaches mentioned before, we mainly consider the borrowing infor-
mation between two studies based on their end point only. For example, we focus on
evaluating the event rate of the studies. In practice, the trial is always complicated
and have factors influencing the results. So we need some tool to systematically in-
corporate all those kinds of factors into the analysis. In Bayesian hierarchical model
section, we have introduced a model based on the binomial likelihood function. The
model is actually can be equally written as:
For the current study, we assume
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1
α1 ∼ N(µa, 1/τa)
µa ∼ N(a, b)
τa ∼ Gamma(c, d)
For the historical study, we assume
y0j ∼ bernoulli(p0j), j = 1, ..., n0
logit(p0i) = α0
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α0 ∼ N(µa, 1/τa)
So here we start to model based on each individual level’s data. Since each individual
data has their specific covariate level or treatment level, then we can incorporate
those effects in the model. First, we will consider to incorporate one covariate effect
into the current study. Then the likelihood of the models will become:
For the current study, we assume
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1 + β1 × x1i
For the historical study, we assume
y0j ∼ bernoulli(p0j), j = 1, ..., n0
logit(p0i) = α0 + β0 × x0j
where, β1 and β0 are the covarate effect parameters.
4.5.2 Methodology
The random effect meta-analysis model is the most commonly used approach for
modeling the results from multiple studies. It generally consider all the corresponding
effect parameters are coming a common distribution. By controlling the variance
of this distribution, we can control how the information can be borrowed between
different studies. So for the above example, the meta-analysis model will regard the
study effects α1 and α0 are coming from the same distribution and β1 and β0 from
another common distribution. For example,
α1, α0 ∼ N(µa, τa)
β1, β0 ∼ N(µb, τb)
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So in the above models, we can control the effect parameters between the studies by
tuning τa and τb. If τa → 0 meaning small variances, the study effect parameter of
α1 will borrow from the data that influence the parameter α0.
In Hobbs (2011, 2012) [67] [68], a novel approach is proposed to more directly
describe the relations between the different studies by ’commensurate’ model. In
the above model, the meta-analysis assumes the parameters are coming from a com-
mon distribution, while ’commensurate’ model assumes that one parameter is a non-
systematically biased representation of another parameter. The model is like this
α0 ∼ N(µa0 , τa0)
α1 ∼ N(α0, γa)
β0 ∼ N(µb0 , τb0)
β1 ∼ N(β0, γb)
As τa → 0, α1 → α0 which means that the two parameters are very close. τa → ∞,
α1 and α0 are independent. The ’commensurate’ means that the two parameters are
not that different, so the idea sounds like the BMA approach which construct the
model based on the closeness between the studies’ endpoint values. Now if we have
more than 1 historical study to borrow, the model for the two study will be extended.
Then it apply the homogeneity model to model all the historical data set and model
the parameter of the current based on the parameter from the historical parameters.
Next we will first take a look at an example of two studies with one covariate.
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4.5.3 Case 1: Two Studies with One Covariate in Each Study
Methodology
Here, suppose that we have two studies with responses y0i and y1j that are binary
data for each patient. We assume that we will have diabetic patient in the current
study, such that one covariate is considered in the current study. The full model of
the commensurate model is as follows:
For the current study, we assume
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1 + β1 × x1i
α1 ∼ N(α0, γa)
β1 ∼ N(β0, γb)
For the historical study, we assume
y0j ∼ bernoulli(p0j), j = 1, ..., n0
logit(p0i) = α0
α0 ∼ N(µa0 , τa0)
We want to evaluate the covariate effect parameter β1 with the study effect α1. As
mentioned earlier, the random-effect meta-analysis model is:
For the current study, we assume
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1 + β1 × x1i
For the historical study, we assume
y0j ∼ bernoulli(p0j), j = 1, ..., n0
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logit(p0i) = α0 + β0 × x0j
α1, α0 ∼ N(µa, τa)
β1, β0 ∼ N(µb, τb)
For comparison reason, we also consider the single study model with the current
study group only,
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1 + β1 × x1i
α1 ∼ N(µa, τa)
β1 ∼ N(µb, τb)
In the last, a homogeneity model is considered for comparison:
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α + β × x1i
y0j ∼ bernoulli(p0j), j = 1, ..., n0
logit(p0i) = α
α ∼ N(µa, τa)
β ∼ N(µb, τb)
Simulation
For comparison reasons, We assume the prevalence of the covariate is 0.5 in the
current study. The null hypothesis for the event rate of patient without diabetes is
H0 : p10 ≥ 0.2
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The null hypothesis for the event rate of patient with diabetes is
H
′
0 : p1 ≥ 0.3
This is not a multiple test case. In Bayesian frame work, if pr(p1 < 0.2|data) > 0.95
we will reject null hypothesis for pr(p
′
1 < 0.3|data) > 0.95. For the parameter setup
we will use logit transformation to get the true value for the parameters. For example,
for the current study, if we set p0 = 0.2, p11 = 0.3 and p10 = 0.2, then
α0 = α1 = logit(0.2) = −1.386
β = logit(0.3)− logit(0.2) = 0.539
if we set p0 = 0.1
α0 = −2.197
Results
Table 4.5 and 4.6 summarize the results for analyzing the data from 2 studies with
the covariate in the current study. When the sample size is 80 for historical study and
40 for the current study, we find that overall the performance of the power is not ap-
pealing. When commensurate model performs slightly better than the meta-analysis
approach. If the historical rate p0 is same as the current rate for the non-diabetic
patient, the commensurate and meta-analysis are performing similarly as the best
model ’homogeneity’ in this situation. However, when the true rate for the historical
study is 0.1, the Type-I error rate is unacceptably inflated, although the Type-I error
for the commensurate and meta-analysis is also inflated. So overall the commensurate
is the best among all the models considered.
When we increase the sample size of the study to n0 = 200 and n1 = 100, we
observed that commensurate model perform also the best among all the four models.
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When we even increase more sample size on both of the studies, we can see that the
Type-I error is better controlled than the single study, while they all have acceptable
power. This study is useful because we always want to evaluate the effects on the
subgroup of the current arm.
4.5.4 Case 2: Two Studies with One Covariate and One Treatment
Methods
In practical clinical trial studies, we often meet the case in which the current trial
is a randomized trial. This is a kind of typical trial scenario in device clinical trial
study, because we often has some historical information on one arm and we want to
evaluate the treatment effect from the other arm. So we have the model for the data:
For the current study, we assume
y1i ∼ bernoulli(p1i), i = 1, ..., n1
logit(p1i) = α1 + β1 × x1i + βtrt × xtrt
For the historical study, we assume
y0j ∼ bernoulli(p0j), j = 1, ..., n0
logit(p0i) = α0 + β2 × x2j
Simulations
By doing simulations, we want to see how the different Bayesian approaches can
estimate the parameter of interest. In the setup we assume that there are 100 patients
in the current study and 200 in the historical study. In both of the studies we
assume that the prevalence of the covariate (diabetic factor) is 0.5 in both. In the
current study of randomized trial, we assume that the treatment allocation is 0.5. We
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n0 = 80 p0 0.2 0.2 0.2 0.2
n1 = 40 p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.03 0.05 0.03 0.13 0.02 0.25 0.01 0.49
Meta-analysis 0.04 0.06 0.04 0.14 0.04 0.28 0.04 0.54
Single study 0.18 0.06 0.19 0.14 0.19 0.27 0.17 0.52
Homogeneity 0.04 0.06 0.04 0.14 0.04 0.27 0.04 0.52
p0 0.1 0.1 0.1 0.1
p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.46 0.05 0.47 0.13 0.48 0.25 0.47 0.49
Meta-analysis 0.55 0.06 0.55 0.14 0.54 0.27 0.52 0.51
Single study 0.18 0.06 0.19 0.14 0.19 0.27 0.17 0.52
Homogeneity 0.72 0.06 0.76 0.14 0.76 0.27 0.77 0.52
n0 = 200 p0 0.2 0.2 0.2 0.2
n1 = 100 p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.01 0.05 0.01 0.17 0.01 0.47 0.01 0.81
Meta-analysis 0.03 0.06 0.03 0.18 0.03 0.49 0.03 0.82
Single study 0.08 0.07 0.07 0.20 0.09 0.54 0.09 0.85
Homogeneity 0.05 0.06 0.05 0.20 0.04 0.53 0.04 0.84
p0 0.1 0.1 0.1 0.1
p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.55 0.05 0.53 0.17 0.51 0.47 0.52 0.79
Meta-analysis 0.56 0.05 0.54 0.16 0.53 0.48 0.49 0.79
Single study 0.08 0.07 0.07 0.20 0.09 0.54 0.09 0.85
Homogeneity 0.97 0.06 0.97 0.20 0.97 0.54 0.97 0.85
Table 4.5: Frequentist operating characteristics for different models with different
sample sizes in the historical and current studies
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n0 = 500 p0 0.2 0.2 0.2 0.2
n1 = 300 p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.02 0.03 0.02 0.39 0.02 0.92 0.02 1.00
Meta-analysis 0.03 0.05 0.03 0.41 0.03 0.92 0.02 1.00
Single study 0.08 0.05 0.08 0.41 0.08 0.94 0.07 1.00
Homogeneity 0.07 0.05 0.07 0.41 0.07 0.92 0.07 1.00
p0 0.1 0.1 0.1 0.1
p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.27 0.03 0.28 0.39 0.26 0.92 0.26 1.00
Meta-analysis 0.28 0.05 0.28 0.41 0.30 0.92 0.28 1.00
Single study 0.08 0.05 0.08 0.41 0.08 0.94 0.07 1.00
Homogeneity 1.00 0.05 1.00 0.41 1.00 0.92 1.00 1.00
n0 = 1000 p0 0.2 0.2 0.2 0.2
n1 = 1000 p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.01 0.03 0.01 0.75 0.01 1.00 0.01 1.00
Meta-analysis 0.01 0.03 0.02 0.77 0.01 1.00 0.01 1.00
Single study 0.03 0.03 0.03 0.74 0.03 1.00 0.04 1.00
Homogeneity 0.07 0.03 0.07 0.74 0.07 1.00 0.07 1.00
p0 0.1 0.1 0.1 0.1
p10 p11 0.2 0.3 0.2 0.25 0.2 0.2 0.2 0.15
Type-I Type-I Type-I Power Type-I Power Type-I Power
Commensurate 0.06 0.03 0.06 0.69 0.06 1.00 0.06 1.00
Meta-analysis 0.05 0.03 0.05 0.76 0.05 1.00 0.05 1.00
Single study 0.03 0.03 0.03 0.74 0.03 1.00 0.04 1.00
Homogeneity 1.00 0.03 1.00 0.74 1.00 1.00 1.00 1.00
Table 4.6: (cont.)Frequentist operating characteristics for different models with dif-
ferent sample sizes in the historical and current studies
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totally run two scenarios, in the first scenario we assume that the treatment effect
is βtrt = −0.887 in the current study, which corresponds to decrease the event rate
from 0.3 to 0.15. In the second scenario we just assume no effect of the treatments.
In both of the studies, we assume that the study effects are same and also for the
covariate effect.
Results
In figure 7 and 8, we showed the results of mean estimates of the treatment effect
parameters. Under these two scenarios, the homogeneity should be the ’true’ model
which means that its model assumption best fit the simulation setup of parameters. So
in both of scenarios, the commensurate model perform better than the meta-analysis
approach and single study. In Hobbs (2012) [68], it mentioned that the random effects
meta-analysis will not effectively borrow information when the similarity between the
studies is obvious. So this simulation results show the aspect that the commensurate
model can improve the inference of treatment effects.
4.5.5 Summary
In this section, we compare the ’commensurate’, ’meta-analysis’, ’single study’
and ’homogeneity’ models. First we setup a two groups study with one covariate
considered. This model is useful in practice when we want to evaluate the device
improvements or confirm the device’s efficacy in specific subgroups. The results show
that the commensurate and meta-analysis approaches effectively increase the power
and comparably control the Type-I error. There exist certain situation in which the
two study we investigate are similar but they are conflicting with our target, such
as rejecting null hypothesis to claim the power. In such cases, the more powerful
borrowing approach definitely will decrease the study effects. So in this situation, the
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Figure 4.9.: Parameter estimate performance in 1000 simulations for Scenario 1
study is subjective that we can not improve the results. However, we often have some
useful historical studies which means they will make efficient our current study. That
is the case in which we should borrow the information. And both commensurate and
meta-analysis models have been shown to reach this goal.
We also compare the commensurate and meta-analysis approaches. In the first
study, in most situations the commensurate outperform the meta-analysis. In certain
situations, as we mentioned earlier, when both of the studies conflict with our target,
the more powerful approach will make worse results.
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Figure 4.10.: Parameter estimate performance in 1000 simulations for Scenario 2
One of the most important feature of commensurate model is the ’commensurate
prior’ that describe the closeness between the parameters from different studies. There
can be different hyper-priors models for the commensurate variance parameters. We
have also tried to use ’spike and slab’ prior as in Hobbs (2012) [68]. Just as the paper
points out, all prior models are sort of subjective. The performance of the priors
proposed will highly depend on the pattern of data from different groups and also also
depends on the question we want to answer(for example, different hypothesis target).
So this work surely need to be improved and calibrated well to fit the objective of
study. Also, in all studies we tried, we only assume two studies. One of assumptions
for the ’commensurate’ model is that it assumes the homogeneity between the different
historical groups. This is also a strong assumption that need to be evaluated before
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Figure 4.11.: Parameter estimate performance in 1000 simulations for Scenario 3
any practical studies. One possible solution for this problem is that we may condition
each historical study on the current study parameters. This could be an interesting
extension for the future work.
Discussion
In this project, we mainly worked on four kinds of models which are designed
for different type of questions about adaptive borrowing information from histori-
cal studies. In each study, we have shown the advantages of the models compared
with frequentist approaches and existing Bayesian approach. We novelly develop the
empirical Bayesian shrinkage type estimate and the Bayesian model averaging ap-
proaches. These approaches have shown the property of borrowing information based
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Figure 4.12.: Parameter estimate performance in 1000 simulations for Scenario 4
on the similarity between studies. The hierarchical model is a good way to decide
the sample size when we want to use Bayesian approach to improve the performance
of the study based on the current data as shown in Pennello and Thompson (2008)
[69]. The commensurate is the most flexible approach among the four approaches we
considered. We can incorporate different covariate factors in the study and also incor-
porate the treatment effect as in a randomized trial study. These flexibility properties
will facilitate the subgroup analysis and the combining study of randomized clinical
trials and single arm historical results. In conclusion, we show the non-comparable
capability of Bayesian approach to handle the problem of borrowing information for
medical device clinical trial studies.
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5. Conclusion and Future Research
In this dissertation, we focused on investigating and developing Bayesian statistical
methods for the modeling of genetic interactions. First, we introduced the definition
of interactions in statistics. There are several statistical approaches available for de-
tecting the gene-gene (epistasis) and gene-environment interactions. To provide the
background about our proposed methods, we discussed two models: the penalized
regression model and the shrinkage prior model that are widely applied in interaction
studies.
In Chapter 2, we introduced a logistic regression based variable selection approach
for gene-environment and gene-gene interaction studies. When building up the mod-
els with multiple factors, statisticians have a natural preference to include the inter-
action terms with the corresponding main effect terms. This can make the model
more parsimonious and interpretable. In frequentist machine learning literature, this
statistical constraint has been incorporated into different methods, such as Linear
models, Lars and Lasso. In the Bayesian areas, there are relatively fewer papers ex-
ploring this topic. Therefore, we merged this constraint with the Bayesian variable
selection framework. Under the logistic regression model, we proposed a Bayesian
mixture model which represented the two hypotheses about the effect of each factor.
We designed the ’Strong hierarchical’ and ’Weak hierarchical’ models by proposing
different prior structures for the indicators of the priors. The extensive simulation
and real data studies demonstrated the superiority of the proposed models over the
other models considered. In the future research, we may consider comparing the per-
formances with the other statistical models such as Random Forest or Multi-factor
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Dimension Reductions for detecting the interactions. Due to the computational bur-
dens of the Bayesian methods, the methods proposed in this project can be considered
as a second step analysis after finishing the Genome-wide interaction studies by the
frequentist approaches, such as the Bayesian empirical shrinkage-type estimator. Se-
lecting subjective priors is another challenge in Bayesian variable selection. We also
tried to develop a method using Bayesian model averaging technique to account for
the uncertainty while eliciting the priors among the competing models. In the future
research, we may strive to explore a systematic way to specify the priors, on which
the Bayesian model averaging/selection can be applied more efficiently.
In Chapter 3, we investigated the Bayesian complementary version of the Natural
and Orthogonal Interaction (NOIA) model for gene-environment interaction studies.
The NOIA model allows us to estimate the genetic and environment orthogonally
and decompose the total variances according to each effect. This feature is especially
useful when dealing with multiple genetic and environmental factors that are usually
confounded with each other. So we developed the Bayesian NOIA model, in which
the estimates of the parameters lead to higher power and lower Type-I error. Also,
we can assign proper priors based on the existing biological information or previous
study results for yielding more satisfactory operating characteristics. We compared
the proposed Bayesian NOIA model with the Bayesian usual functional model by
analyzing the lung cancer data set. The results have shown that the Bayesian model
correctly detect more positive effects which have been reported before. In the next
level of research, we can try to combine this with the hierarchical interaction models
from Chapter 2 which will effectively take advantages of both approaches.
In chapter 4, we first reviewed two Bayesian approaches that have been successfully
applied in the gene-environment interaction studies. The case-control study yielded
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the unbiased result for detecting the interactions but it tended to result in under-
expected powers. The case-only study has a larger power to detect the interaction.
However, the departure from the independency assumption may dramatically bias
the study result. So the Bayesian empirical shrinkage-type estimator and Bayesian
model averaging approaches were proposed to let the data decide on borrowing based
on the uncertainty within the selection of types of the studies. These approaches
would solve the dilemma of bias and variance trade-off in the gene-environment case-
control studies. In the real data analysis, we always encounter the situation where we
need to consider borrowing historical data into the current study to enrich the sample
size. There are many characteristics that determine the eligibility of borrowing from
the historical studies. In this project, we focused on making the decisions about bor-
rowing based on the homogeneity among the studies. When the data from historical
studies are pooled together with the current ones, the sample size will be enlarged.
The departure from the homogeneity assumption will significantly risk the result of
borrowing data. Inspired by the two Bayesian approaches in gene-environment in-
teractions, we proposed the analogous Bayesian empirical shrinkage-type estimator
and the Bayesian model averaging approaches for borrowing the historical data in an
adaptive way. The simulation results have shown that the two Bayesian approaches
have the property to automatically decide the strength borrowed from the historical
data. The asymptotic property of the empirical estimator has also been discussed, so
the hypothesis test could be conducted. In the Bayesian model averaging approach,
the uncertainty among the model selection is considered in finding the posterior dis-
tribution of the model averaging estimator. Further more, we developed the Bayesian
model averaging approach for the scenarios where some degree of departure from the
homogeneity is allowed. The results from borrowing will depend on the equivalence
margin selected. In the last, we discussed some other advanced Bayesian methods
that could be applied on these studies. Overall, these could be one of the future
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research directions that have a broad range of meanings for various studies, such as
the meta-analysis problem in the genetic and clinical studies, the sequencing data
analysis with the previous results and the adaptive clinical trial design with the ef-
fective historical information, which I will continue to explore in my future work.
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